-1 #(S1 (S (S (NP (NP (NNS Cytokines) (NNS measurements)) (PP (IN during) (NP (NN _PROT1_) (NN treatment)))) (VP (VBD showed) (NP (NP (DT a) (NN trend)) (PP (TO to) (NP (NP (VBG decreasing) (NNS levels)) (PP (IN of) (NP (NN _PROT2_)))))) (PP (IN at) (NP (QP (CD 4) (, ,) (CD 12) (, ,) (CC and) (CD 24)) (NNS weeks))))) (. .)))
-1 #(S1 (S (S (NP (NP (NNS Levels)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBD were) (ADVP (RB slightly)) (VP (VBN increased) (PP (VBG following) (NP (NP (NN _PROT2_) (NN treatment)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.09)) (-RRB- -RRB-))))))) (. .)))
-1 #(S1 (S (S (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (JJ complete) (NN response)) (PP (TO to) (NP (NN _PROT1_))))))) (, ,) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT2_)))) (VP (VBD were) (ADJP (JJR higher) (PP (IN at) (NP (NP (CD 24) (NNS weeks)) (VP (VBG following) (NP (NN _PROT_) (NN treatment)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN pre-treatment)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.04)) (-RRB- -RRB-)))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBD decreased) (ADVP (RB markedly)) (PP (IN at) (NP (QP (CD 12) (CC and) (CD 24)) (NNS weeks))) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.02)) (, ,) (NP (NP (CD 0.03)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (. .)) (S (NP (NN mRNA) (NN expression)) (ADVP (RB positively)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN Th1/Th2) (NN type) (NNS cytokines))) (PP (IN in) (NP (DT the) (NN supernatant)))))))) (. .)))
-1 #(S1 (S (S (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (JJ complete) (NN response)) (PP (TO to) (NP (NN _PROT1_))))))) (, ,) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBD were) (ADJP (JJR higher) (PP (IN at) (NP (NP (CD 24) (NNS weeks)) (VP (VBG following) (NP (NN _PROT2_) (NN treatment)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN pre-treatment)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.04)) (-RRB- -RRB-)))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBD decreased) (ADVP (RB markedly)) (PP (IN at) (NP (QP (CD 12) (CC and) (CD 24)) (NNS weeks))) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.02)) (, ,) (NP (NP (CD 0.03)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (. .)) (S (NP (NN mRNA) (NN expression)) (ADVP (RB positively)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN Th1/Th2) (NN type) (NNS cytokines))) (PP (IN in) (NP (DT the) (NN supernatant)))))))) (. .)))
-1 #(S1 (S (S (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (JJ complete) (NN response)) (PP (TO to) (NP (NN _PROT1_))))))) (, ,) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBD were) (ADJP (JJR higher) (PP (IN at) (NP (NP (CD 24) (NNS weeks)) (VP (VBG following) (NP (NN _PROT_) (NN treatment)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN pre-treatment)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.04)) (-RRB- -RRB-)))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT2_)))) (VP (VBD decreased) (ADVP (RB markedly)) (PP (IN at) (NP (QP (CD 12) (CC and) (CD 24)) (NNS weeks))) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.02)) (, ,) (NP (NP (CD 0.03)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (. .)) (S (NP (NN mRNA) (NN expression)) (ADVP (RB positively)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN Th1/Th2) (NN type) (NNS cytokines))) (PP (IN in) (NP (DT the) (NN supernatant)))))))) (. .)))
-1 #(S1 (S (S (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (JJ complete) (NN response)) (PP (TO to) (NP (NN _PROT_))))))) (, ,) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBD were) (ADJP (JJR higher) (PP (IN at) (NP (NP (CD 24) (NNS weeks)) (VP (VBG following) (NP (NN _PROT2_) (NN treatment)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN pre-treatment)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.04)) (-RRB- -RRB-)))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBD decreased) (ADVP (RB markedly)) (PP (IN at) (NP (QP (CD 12) (CC and) (CD 24)) (NNS weeks))) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.02)) (, ,) (NP (NP (CD 0.03)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (. .)) (S (NP (NN mRNA) (NN expression)) (ADVP (RB positively)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN Th1/Th2) (NN type) (NNS cytokines))) (PP (IN in) (NP (DT the) (NN supernatant)))))))) (. .)))
-1 #(S1 (S (S (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (JJ complete) (NN response)) (PP (TO to) (NP (NN _PROT_))))))) (, ,) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBD were) (ADJP (JJR higher) (PP (IN at) (NP (NP (CD 24) (NNS weeks)) (VP (VBG following) (NP (NN _PROT_) (NN treatment)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN pre-treatment)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.04)) (-RRB- -RRB-)))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT2_)))) (VP (VBD decreased) (ADVP (RB markedly)) (PP (IN at) (NP (QP (CD 12) (CC and) (CD 24)) (NNS weeks))) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.02)) (, ,) (NP (NP (CD 0.03)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (. .)) (S (NP (NN mRNA) (NN expression)) (ADVP (RB positively)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN Th1/Th2) (NN type) (NNS cytokines))) (PP (IN in) (NP (DT the) (NN supernatant)))))))) (. .)))
-1 #(S1 (S (S (S (PP (IN In) (NP (NP (NNS patients)) (PP (IN with) (NP (NP (DT a) (JJ complete) (NN response)) (PP (TO to) (NP (NN _PROT_))))))) (, ,) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT_)))) (VP (VBD were) (ADJP (JJR higher) (PP (IN at) (NP (NP (CD 24) (NNS weeks)) (VP (VBG following) (NP (NN _PROT1_) (NN treatment)) (PP (IN than) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN pre-treatment)) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.04)) (-RRB- -RRB-)))))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN _PROT2_)))) (VP (VBD decreased) (ADVP (RB markedly)) (PP (IN at) (NP (QP (CD 12) (CC and) (CD 24)) (NNS weeks))) (PRN (-LRB- -LRB-) (NP (NN P) (JJ =) (CD 0.02)) (, ,) (NP (NP (CD 0.03)) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-)))) (. .)) (S (NP (NN mRNA) (NN expression)) (ADVP (RB positively)) (VP (VBD correlated) (PP (IN with) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN Th1/Th2) (NN type) (NNS cytokines))) (PP (IN in) (NP (DT the) (NN supernatant)))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT1_) (NNS antagonists)) (VP (VB emerge) (PP (IN from) (NP (NP (NNS alterations)) (PP (IN in) (NP (NP (DT the) (JJ low-affinity) (NN binding) (NN epitope)) (PP (IN for) (NP (NN receptor) (NN _PROT2_))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN _PROT1_) (JJ _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VP (VBZ induces) (NP (NP (NN bone) (NN formation)) (CC and) (NP (NN regeneration))) (PP (IN in) (NP (JJ adult) (NNS vertebrates)))) (CC and) (VP (VBZ regulates) (NP (JJ important) (JJ developmental) (NNS processes)) (PP (IN in) (NP (DT all) (NNS animals)))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT1_)) (VP (VBZ is) (NP (NP (DT a) (JJ homodimeric) (NN cysteine) (NN knot) (NN protein)) (SBAR (WHNP (WDT that)) (S (, ,) (PP (IN as) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (NP (DT the) (VBG _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (NN superfamily))))) (, ,) (VP (VBZ signals) (PP (IN by) (S (VP (VBG oligomerizing) (NP (NP (NP (NP (NN type) (CD I)) (CC and) (NP (NN type) (CD II))) (NN receptor) (NNS serine-kinases)) (PP (IN in) (NP (DT the) (NN cell) (NN membrane))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT1_)) (VP (VBZ is) (NP (NP (DT a) (JJ homodimeric) (NN cysteine) (NN knot) (NN protein)) (SBAR (WHNP (WDT that)) (S (, ,) (PP (IN as) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (NP (DT the) (VBG _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN superfamily))))) (, ,) (VP (VBZ signals) (PP (IN by) (S (VP (VBG oligomerizing) (NP (NP (NP (NP (NN type) (CD I)) (CC and) (NP (NN type) (CD II))) (NN receptor) (NNS serine-kinases)) (PP (IN in) (NP (DT the) (NN cell) (NN membrane))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT_)) (VP (VBZ is) (NP (NP (DT a) (JJ homodimeric) (NN cysteine) (NN knot) (NN protein)) (SBAR (WHNP (WDT that)) (S (, ,) (PP (IN as) (NP (NP (DT a) (NN member)) (PP (IN of) (NP (NP (NP (DT the) (VBG _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (NN superfamily))))) (, ,) (VP (VBZ signals) (PP (IN by) (S (VP (VBG oligomerizing) (NP (NP (NP (NP (NN type) (CD I)) (CC and) (NP (NN type) (CD II))) (NN receptor) (NNS serine-kinases)) (PP (IN in) (NP (DT the) (NN cell) (NN membrane))))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (NN binding) (NNS epitopes)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN for) (NP (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN I)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_))) (PRN (-LRB- -LRB-) (NP (NN type) (NN II)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN characterized) (S (VP (VBG using) (NP (JJ _PROT_) (JJ mutant) (NNS proteins)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN receptor) (NNS ectodomains)))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (NN binding) (NNS epitopes)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN for) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN I)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_))) (PRN (-LRB- -LRB-) (NP (NN type) (NN II)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN characterized) (S (VP (VBG using) (NP (JJ _PROT_) (JJ mutant) (NNS proteins)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN receptor) (NNS ectodomains)))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (NN binding) (NNS epitopes)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN for) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN I)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_))) (PRN (-LRB- -LRB-) (NP (NN type) (NN II)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN characterized) (S (VP (VBG using) (NP (JJ _PROT_) (JJ mutant) (NNS proteins)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN receptor) (NNS ectodomains)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN binding) (NNS epitopes)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN for) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN I)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_))) (PRN (-LRB- -LRB-) (NP (NN type) (NN II)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN characterized) (S (VP (VBG using) (NP (JJ _PROT2_) (JJ mutant) (NNS proteins)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN receptor) (NNS ectodomains)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN binding) (NNS epitopes)) (PP (IN of) (NP (NN _PROT_))) (PP (IN for) (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN I)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_))) (PRN (-LRB- -LRB-) (NP (NN type) (NN II)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN characterized) (S (VP (VBG using) (NP (JJ _PROT_) (JJ mutant) (NNS proteins)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN receptor) (NNS ectodomains)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN binding) (NNS epitopes)) (PP (IN of) (NP (NN _PROT_))) (PP (IN for) (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN I)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_))) (PRN (-LRB- -LRB-) (NP (NN type) (NN II)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN characterized) (S (VP (VBG using) (NP (JJ _PROT_) (JJ mutant) (NNS proteins)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN receptor) (NNS ectodomains)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN binding) (NNS epitopes)) (PP (IN of) (NP (NN _PROT_))) (PP (IN for) (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN I)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_))) (PRN (-LRB- -LRB-) (NP (NN type) (NN II)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN characterized) (S (VP (VBG using) (NP (JJ _PROT2_) (JJ mutant) (NNS proteins)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN receptor) (NNS ectodomains)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN binding) (NNS epitopes)) (PP (IN of) (NP (NN _PROT_))) (PP (IN for) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN I)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN _PROT1_)) (CC or) (NP (NN _PROT2_))) (PRN (-LRB- -LRB-) (NP (NN type) (NN II)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN characterized) (S (VP (VBG using) (NP (JJ _PROT_) (JJ mutant) (NNS proteins)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN receptor) (NNS ectodomains)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN binding) (NNS epitopes)) (PP (IN of) (NP (NN _PROT_))) (PP (IN for) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN I)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN _PROT1_)) (CC or) (NP (NN _PROT_))) (PRN (-LRB- -LRB-) (NP (NN type) (NN II)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN characterized) (S (VP (VBG using) (NP (JJ _PROT2_) (JJ mutant) (NNS proteins)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN receptor) (NNS ectodomains)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN binding) (NNS epitopes)) (PP (IN of) (NP (NN _PROT_))) (PP (IN for) (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN type) (NN I)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT1_))) (PRN (-LRB- -LRB-) (NP (NN type) (NN II)) (-RRB- -RRB-)))))) (VP (VBD were) (VP (VBN characterized) (S (VP (VBG using) (NP (JJ _PROT2_) (JJ mutant) (NNS proteins)) (PP (IN for) (NP (NP (NN analysis)) (PP (IN of) (NP (NP (NNS interactions)) (PP (IN with) (NP (NN receptor) (NNS ectodomains)))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT A) (JJ large) (NN epitope) (CD 1)) (PP (IN for) (NP (JJ high-affinity) (NN _PROT1_) (NN binding)))) (VP (VBD was) (VP (VBN detected) (S (VP (VBG spanning) (NP (NP (DT the) (NN interface)) (PP (IN of) (NP (DT the) (JJ _PROT2_) (NN dimer))))))))) (. .)))
+1 #(S1 (S (NP (NP (NN Reconstitution)) (PP (IN of) (NP (NP (DT the) (JJ multiprotein) (NN complex)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_)))))) (PP (IN in) (NP (DT a) (JJ cell-free) (NN system))) (. .))))
-1 #(S1 (S (NP (NP (NN Reconstitution)) (PP (IN of) (NP (NP (DT the) (JJ multiprotein) (NN complex)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_)))))) (PP (IN in) (NP (DT a) (JJ cell-free) (NN system))) (. .))))
-1 #(S1 (S (NP (NP (NN Reconstitution)) (PP (IN of) (NP (NP (DT the) (JJ multiprotein) (NN complex)) (PP (IN of) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_)))))) (PP (IN in) (NP (DT a) (JJ cell-free) (NN system))) (. .))))
-1 #(S1 (S (S (NP (NP (DT A) (NP (NN rabbit) (NN reticulocyte) (NN lysate)) (NN system)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB reconstitute) (NP (NP (JJ functional) (NNS complexes)) (PP (IN between) (NP (NP (NN steroid) (NNS receptors)) (CC and) (NP (NP (DT the) (JJ 90-kDa) (NN heat) (NN shock) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))))))))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB here)) (S (VP (TO to) (VP (VB form) (NP (NP (NNS complexes)) (PP (IN between) (NP (NP (DT the) (NN _PROT2_) (NN tyrosine) (NN kinase)) (CC and) (NP (NN _PROT_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT A) (NP (NN rabbit) (NN reticulocyte) (NN lysate)) (NN system)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB reconstitute) (NP (NP (JJ functional) (NNS complexes)) (PP (IN between) (NP (NP (NN steroid) (NNS receptors)) (CC and) (NP (NP (DT the) (JJ 90-kDa) (NN heat) (NN shock) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))))))))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB here)) (S (VP (TO to) (VP (VB form) (NP (NP (NNS complexes)) (PP (IN between) (NP (NP (DT the) (NN _PROT_) (NN tyrosine) (NN kinase)) (CC and) (NP (NN _PROT2_)))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT A) (NP (NN rabbit) (NN reticulocyte) (NN lysate)) (NN system)) (SBAR (WHNP (WDT that)) (S (VP (VBZ has) (VP (VBN been) (VP (VBN used) (S (VP (TO to) (VP (VB reconstitute) (NP (NP (JJ functional) (NNS complexes)) (PP (IN between) (NP (NP (NN steroid) (NNS receptors)) (CC and) (NP (NP (DT the) (JJ 90-kDa) (NN heat) (NN shock) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))))))))))))))) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (ADVP (RB here)) (S (VP (TO to) (VP (VB form) (NP (NP (NNS complexes)) (PP (IN between) (NP (NP (DT the) (NN _PROT1_) (NN tyrosine) (NN kinase)) (CC and) (NP (NN _PROT2_)))))))))))) (. .)))
+1 #(S1 (S (NP (NN Reticulocyte) (NN lysate)) (VP (VBZ forms) (NP (NP (NNS complexes)) (PP (IN between) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NP (DT a) (JJ temperature-sensitive) (NN mutant)) (PP (IN of) (NP (NP (NN Rous) (NN sarcoma) (NN virus)) (NN _PROT2_))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADVP (RB normally)) (ADJP (JJ present) (PP (IN in) (NP (NN cytosol))) (PP (ADVP (RB virtually) (RB entirely)) (IN in) (NP (NP (DT the) (JJ multiprotein) (NN complex)) (NN form))))))))))) (. .)))
+1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN _PROT1_)) (PP (IN in) (NP (NP (DT the) (NN lysate) (NNS complexes)) (PP (IN with) (NP (JJ wild-type) (NN _PROT2_))) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (RB only) (DT a) (JJ small) (NN portion)) (VP (VBZ is) (ADVP (RB normally)) (VP (VBN recovered) (PP (PP (IN in) (NP (NP (NN cytosol)) (PP (IN in) (NP (DT the) (JJ native) (JJ multiprotein) (NN complex))))) (, ,) (CC and) (PP (IN with) (NP (NP (DT the) (JJ cellular) (NN homolog)) (, ,) (NP (NN _PROT_)) (, ,)))))))))) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB never)) (VP (VBN been) (VP (VBN recovered) (PP (IN in) (NP (NN cytosol))) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (DT a) (JJ native) (JJ multiprotein) (NN complex)) (PP (IN with) (NP (NN _PROT_))))))))))))) (. .)))
+1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN _PROT1_)) (PP (IN in) (NP (NP (DT the) (NN lysate) (NNS complexes)) (PP (IN with) (NP (JJ wild-type) (NN _PROT_))) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (RB only) (DT a) (JJ small) (NN portion)) (VP (VBZ is) (ADVP (RB normally)) (VP (VBN recovered) (PP (PP (IN in) (NP (NP (NN cytosol)) (PP (IN in) (NP (DT the) (JJ native) (JJ multiprotein) (NN complex))))) (, ,) (CC and) (PP (IN with) (NP (NP (DT the) (JJ cellular) (NN homolog)) (, ,) (NP (NN _PROT2_)) (, ,)))))))))) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB never)) (VP (VBN been) (VP (VBN recovered) (PP (IN in) (NP (NN cytosol))) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (DT a) (JJ native) (JJ multiprotein) (NN complex)) (PP (IN with) (NP (NN _PROT_))))))))))))) (. .)))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN _PROT1_)) (PP (IN in) (NP (NP (DT the) (NN lysate) (NNS complexes)) (PP (IN with) (NP (JJ wild-type) (NN _PROT_))) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (RB only) (DT a) (JJ small) (NN portion)) (VP (VBZ is) (ADVP (RB normally)) (VP (VBN recovered) (PP (PP (IN in) (NP (NP (NN cytosol)) (PP (IN in) (NP (DT the) (JJ native) (JJ multiprotein) (NN complex))))) (, ,) (CC and) (PP (IN with) (NP (NP (DT the) (JJ cellular) (NN homolog)) (, ,) (NP (NN _PROT_)) (, ,)))))))))) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB never)) (VP (VBN been) (VP (VBN recovered) (PP (IN in) (NP (NN cytosol))) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (DT a) (JJ native) (JJ multiprotein) (NN complex)) (PP (IN with) (NP (NN _PROT2_))))))))))))) (. .)))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN _PROT_)) (PP (IN in) (NP (NP (DT the) (NN lysate) (NNS complexes)) (PP (IN with) (NP (JJ wild-type) (NN _PROT1_))) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (RB only) (DT a) (JJ small) (NN portion)) (VP (VBZ is) (ADVP (RB normally)) (VP (VBN recovered) (PP (PP (IN in) (NP (NP (NN cytosol)) (PP (IN in) (NP (DT the) (JJ native) (JJ multiprotein) (NN complex))))) (, ,) (CC and) (PP (IN with) (NP (NP (DT the) (JJ cellular) (NN homolog)) (, ,) (NP (NN _PROT2_)) (, ,)))))))))) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB never)) (VP (VBN been) (VP (VBN recovered) (PP (IN in) (NP (NN cytosol))) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (DT a) (JJ native) (JJ multiprotein) (NN complex)) (PP (IN with) (NP (NN _PROT_))))))))))))) (. .)))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN _PROT_)) (PP (IN in) (NP (NP (DT the) (NN lysate) (NNS complexes)) (PP (IN with) (NP (JJ wild-type) (NN _PROT1_))) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (RB only) (DT a) (JJ small) (NN portion)) (VP (VBZ is) (ADVP (RB normally)) (VP (VBN recovered) (PP (PP (IN in) (NP (NP (NN cytosol)) (PP (IN in) (NP (DT the) (JJ native) (JJ multiprotein) (NN complex))))) (, ,) (CC and) (PP (IN with) (NP (NP (DT the) (JJ cellular) (NN homolog)) (, ,) (NP (NN _PROT_)) (, ,)))))))))) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB never)) (VP (VBN been) (VP (VBN recovered) (PP (IN in) (NP (NN cytosol))) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (DT a) (JJ native) (JJ multiprotein) (NN complex)) (PP (IN with) (NP (NN _PROT2_))))))))))))) (. .)))
-1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (NP (NN _PROT_)) (PP (IN in) (NP (NP (DT the) (NN lysate) (NNS complexes)) (PP (IN with) (NP (JJ wild-type) (NN _PROT_))) (, ,) (SBAR (WHPP (IN of) (WHNP (WDT which))) (S (NP (RB only) (DT a) (JJ small) (NN portion)) (VP (VBZ is) (ADVP (RB normally)) (VP (VBN recovered) (PP (PP (IN in) (NP (NP (NN cytosol)) (PP (IN in) (NP (DT the) (JJ native) (JJ multiprotein) (NN complex))))) (, ,) (CC and) (PP (IN with) (NP (NP (DT the) (JJ cellular) (NN homolog)) (, ,) (NP (NN _PROT1_)) (, ,)))))))))) (SBAR (WHNP (WDT which)) (S (VP (VBZ has) (ADVP (RB never)) (VP (VBN been) (VP (VBN recovered) (PP (IN in) (NP (NN cytosol))) (PP (IN in) (NP (NP (DT the) (NN form)) (PP (IN of) (NP (NP (DT a) (JJ native) (JJ multiprotein) (NN complex)) (PP (IN with) (NP (NN _PROT2_))))))))))))) (. .)))
+1 #(S1 (S (S (S (NP (DT The) (ADJP (ADJP (JJ native)) (CC and) (ADJP (JJ reconstituted))) (NN _PROT1_AND_PROT2_) (NNS complexes)) (VP (VBP have) (NP (JJ similar) (JJ thermal) (NN stability)))) (CC and) (S (, ,) (PP (IN like) (NP (NN steroid) (NN receptor) (NNS heterocomplexes))) (, ,) (NP (PRP they)) (VP (VBP are) (VP (VBN stabilized) (PP (IN by) (NP (NN molybdate))))))) (. .)))
+1 #(S1 (S (SBAR (IN As) (S (ADVP (RB previously)) (VP (VBN shown) (PP (IN with) (NP (NN reticulocyte) (JJ lysate-reconstituted) (NN steroid) (NN receptor) (NN heteroprotein) (NNS complexes)))))) (, ,) (NP (DT the) (JJ reconstituted) (NN _PROT1_) (JJ multiprotein) (NN complex)) (VP (VBZ contains) (NP (NP (NN _PROT2_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (JJ major) (NN candidate)) (PP (IN for) (S (VP (VBG providing) (NP (NP (DT the) (NN protein) (NN unfoldase) (NN activity)) (VP (VBN required) (PP (IN for) (NP (NN _PROT_) (NN association)))))))))))))) (. .)))
-1 #(S1 (S (SBAR (IN As) (S (ADVP (RB previously)) (VP (VBN shown) (PP (IN with) (NP (NN reticulocyte) (JJ lysate-reconstituted) (NN steroid) (NN receptor) (NN heteroprotein) (NNS complexes)))))) (, ,) (NP (DT the) (JJ reconstituted) (NN _PROT1_) (JJ multiprotein) (NN complex)) (VP (VBZ contains) (NP (NP (NN _PROT_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (JJ major) (NN candidate)) (PP (IN for) (S (VP (VBG providing) (NP (NP (DT the) (NN protein) (NN unfoldase) (NN activity)) (VP (VBN required) (PP (IN for) (NP (NN _PROT2_) (NN association)))))))))))))) (. .)))
-1 #(S1 (S (SBAR (IN As) (S (ADVP (RB previously)) (VP (VBN shown) (PP (IN with) (NP (NN reticulocyte) (JJ lysate-reconstituted) (NN steroid) (NN receptor) (NN heteroprotein) (NNS complexes)))))) (, ,) (NP (DT the) (JJ reconstituted) (NN _PROT_) (JJ multiprotein) (NN complex)) (VP (VBZ contains) (NP (NP (NN _PROT1_)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (NP (NP (DT a) (JJ major) (NN candidate)) (PP (IN for) (S (VP (VBG providing) (NP (NP (DT the) (NN protein) (NN unfoldase) (NN activity)) (VP (VBN required) (PP (IN for) (NP (NN _PROT2_) (NN association)))))))))))))) (. .)))
-1 #(S1 (S (NP (NP (NN Coassociation)) (PP (IN of) (NP (NP (CD _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (NN _PROT2_) (CD _PROT2_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT_))) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (JJ human) (NN T) (NNS lymphocytes))))) (. .))))
+1 #(S1 (S (NP (NP (NN Coassociation)) (PP (IN of) (NP (NP (CD _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (NN _PROT_) (CD _PROT_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT2_))) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (JJ human) (NN T) (NNS lymphocytes))))) (. .))))
+1 #(S1 (S (NP (NP (NN Coassociation)) (PP (IN of) (NP (NP (CD _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_) (NN _PROT1_) (CD _PROT1_)) (-RRB- -RRB-)))) (PP (IN with) (NP (NN _PROT2_))) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (JJ human) (NN T) (NNS lymphocytes))))) (. .))))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN report))) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN modulation)) (PP (IN of) (NP (NP (CD _PROT1_)) (PP (IN from) (NP (NN T) (NN cell) (NN surface))))) (VP (VBN induced) (PP (IN by) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN 1F7)) (-RRB- -RRB-)))))) (VP (VBD led) (PP (TO to) (NP (NP (NP (VBN enhanced) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_) (NN zeta) (NN tyrosine) (NNS residues)))) (CC and) (NP (VBN increased) (NN _PROT_) (JJ associated) (NN p56lck) (NN tyrosine) (NN kinase) (NN activity)))))))) (. .)))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN report))) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN modulation)) (PP (IN of) (NP (NP (CD _PROT1_)) (PP (IN from) (NP (NN T) (NN cell) (NN surface))))) (VP (VBN induced) (PP (IN by) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN 1F7)) (-RRB- -RRB-)))))) (VP (VBD led) (PP (TO to) (NP (NP (NP (VBN enhanced) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_) (NN zeta) (NN tyrosine) (NNS residues)))) (CC and) (NP (VBN increased) (NN _PROT_) (JJ associated) (NN p56lck) (NN tyrosine) (NN kinase) (NN activity)))))))) (. .)))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN report))) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN modulation)) (PP (IN of) (NP (NP (CD _PROT1_)) (PP (IN from) (NP (NN T) (NN cell) (NN surface))))) (VP (VBN induced) (PP (IN by) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN 1F7)) (-RRB- -RRB-)))))) (VP (VBD led) (PP (TO to) (NP (NP (NP (VBN enhanced) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_) (NN zeta) (NN tyrosine) (NNS residues)))) (CC and) (NP (VBN increased) (NN _PROT2_) (JJ associated) (NN p56lck) (NN tyrosine) (NN kinase) (NN activity)))))))) (. .)))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN report))) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN modulation)) (PP (IN of) (NP (NP (CD _PROT_)) (PP (IN from) (NP (NN T) (NN cell) (NN surface))))) (VP (VBN induced) (PP (IN by) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN 1F7)) (-RRB- -RRB-)))))) (VP (VBD led) (PP (TO to) (NP (NP (NP (VBN enhanced) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_) (NN zeta) (NN tyrosine) (NNS residues)))) (CC and) (NP (VBN increased) (NN _PROT_) (JJ associated) (NN p56lck) (NN tyrosine) (NN kinase) (NN activity)))))))) (. .)))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN report))) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN modulation)) (PP (IN of) (NP (NP (CD _PROT_)) (PP (IN from) (NP (NN T) (NN cell) (NN surface))))) (VP (VBN induced) (PP (IN by) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN 1F7)) (-RRB- -RRB-)))))) (VP (VBD led) (PP (TO to) (NP (NP (NP (VBN enhanced) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_) (NN zeta) (NN tyrosine) (NNS residues)))) (CC and) (NP (VBN increased) (NN _PROT2_) (JJ associated) (NN p56lck) (NN tyrosine) (NN kinase) (NN activity)))))))) (. .)))
-1 #(S1 (S (PP (IN In) (NP (DT the) (JJ present) (NN report))) (, ,) (NP (PRP we)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP (NP (NN modulation)) (PP (IN of) (NP (NP (CD _PROT_)) (PP (IN from) (NP (NN T) (NN cell) (NN surface))))) (VP (VBN induced) (PP (IN by) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN 1F7)) (-RRB- -RRB-)))))) (VP (VBD led) (PP (TO to) (NP (NP (NP (VBN enhanced) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT1_) (NN zeta) (NN tyrosine) (NNS residues)))) (CC and) (NP (VBN increased) (NN _PROT2_) (JJ associated) (NN p56lck) (NN tyrosine) (NN kinase) (NN activity)))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBD was) (VP (VBN comodulated) (PP (IN on) (NP (DT the) (NN T) (NN cell) (NN surface))) (PP (IN with) (NP (NP (NN _PROT2_)) (, ,) (NP (DT a) (JJ known) (JJ membrane-linked) (NN protein) (NN tyrosine) (NN phosphatase)))))))) (CC and) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBD was) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG precipitating) (NP (NN _PROT_)) (PP (IN from) (NP (NN T) (NN cell) (NNS lysates))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBD was) (VP (VBN comodulated) (PP (IN on) (NP (DT the) (NN T) (NN cell) (NN surface))) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ known) (JJ membrane-linked) (NN protein) (NN tyrosine) (NN phosphatase)))))))) (CC and) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (VBD was) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG precipitating) (NP (NN _PROT_)) (PP (IN from) (NP (NN T) (NN cell) (NNS lysates))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBD was) (VP (VBN comodulated) (PP (IN on) (NP (DT the) (NN T) (NN cell) (NN surface))) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ known) (JJ membrane-linked) (NN protein) (NN tyrosine) (NN phosphatase)))))))) (CC and) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBD was) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG precipitating) (NP (NN _PROT2_)) (PP (IN from) (NP (NN T) (NN cell) (NNS lysates))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBD was) (VP (VBN comodulated) (PP (IN on) (NP (DT the) (NN T) (NN cell) (NN surface))) (PP (IN with) (NP (NP (NN _PROT1_)) (, ,) (NP (DT a) (JJ known) (JJ membrane-linked) (NN protein) (NN tyrosine) (NN phosphatase)))))))) (CC and) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (VBD was) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG precipitating) (NP (NN _PROT_)) (PP (IN from) (NP (NN T) (NN cell) (NNS lysates))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBD was) (VP (VBN comodulated) (PP (IN on) (NP (DT the) (NN T) (NN cell) (NN surface))) (PP (IN with) (NP (NP (NN _PROT1_)) (, ,) (NP (DT a) (JJ known) (JJ membrane-linked) (NN protein) (NN tyrosine) (NN phosphatase)))))))) (CC and) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBD was) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG precipitating) (NP (NN _PROT2_)) (PP (IN from) (NP (NN T) (NN cell) (NNS lysates))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (ADVP (RB further)) (VP (VBD showed) (SBAR (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBD was) (VP (VBN comodulated) (PP (IN on) (NP (DT the) (NN T) (NN cell) (NN surface))) (PP (IN with) (NP (NP (NN _PROT_)) (, ,) (NP (DT a) (JJ known) (JJ membrane-linked) (NN protein) (NN tyrosine) (NN phosphatase)))))))) (CC and) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBD was) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG precipitating) (NP (NN _PROT2_)) (PP (IN from) (NP (NN T) (NN cell) (NNS lysates))))))))))))) (. .)))
-1 #(S1 (S (NP (DT These) (NNS findings)) (ADVP (RB strongly)) (VP (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (MD may) (VP (VB be) (ADVP (RB closely)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN _PROT2_) (NN protein) (NN tyrosine) (NN phosphatase)) (PP (IN on) (NP (NN T) (NN cell) (NN surface))))))))))) (CC and) (VP (ADVP (RB further)) (VBP support) (NP (DT the) (NN notion) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (CD _PROT_))) (PP (IN with) (NP (NN _PROT_)))) (VP (VBZ results) (PP (IN in) (NP (NP (VBN enhanced) (NN tyrosine) (NN kinase) (NN activity)) (, ,) (NP (NN zeta) (NN chain) (NN phosphorylation)) (, ,) (CC and) (NP (NN T) (NN cell) (NN activation)))))))))) (. .)))
-1 #(S1 (S (NP (DT These) (NNS findings)) (ADVP (RB strongly)) (VP (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (MD may) (VP (VB be) (ADVP (RB closely)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN _PROT_) (NN protein) (NN tyrosine) (NN phosphatase)) (PP (IN on) (NP (NN T) (NN cell) (NN surface))))))))))) (CC and) (VP (ADVP (RB further)) (VBP support) (NP (DT the) (NN notion) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (CD _PROT2_))) (PP (IN with) (NP (NN _PROT_)))) (VP (VBZ results) (PP (IN in) (NP (NP (VBN enhanced) (NN tyrosine) (NN kinase) (NN activity)) (, ,) (NP (NN zeta) (NN chain) (NN phosphorylation)) (, ,) (CC and) (NP (NN T) (NN cell) (NN activation)))))))))) (. .)))
-1 #(S1 (S (NP (DT These) (NNS findings)) (ADVP (RB strongly)) (VP (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (MD may) (VP (VB be) (ADVP (RB closely)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN _PROT_) (NN protein) (NN tyrosine) (NN phosphatase)) (PP (IN on) (NP (NN T) (NN cell) (NN surface))))))))))) (CC and) (VP (ADVP (RB further)) (VBP support) (NP (DT the) (NN notion) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (CD _PROT_))) (PP (IN with) (NP (NN _PROT2_)))) (VP (VBZ results) (PP (IN in) (NP (NP (VBN enhanced) (NN tyrosine) (NN kinase) (NN activity)) (, ,) (NP (NN zeta) (NN chain) (NN phosphorylation)) (, ,) (CC and) (NP (NN T) (NN cell) (NN activation)))))))))) (. .)))
-1 #(S1 (S (NP (DT These) (NNS findings)) (ADVP (RB strongly)) (VP (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (MD may) (VP (VB be) (ADVP (RB closely)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN _PROT1_) (NN protein) (NN tyrosine) (NN phosphatase)) (PP (IN on) (NP (NN T) (NN cell) (NN surface))))))))))) (CC and) (VP (ADVP (RB further)) (VBP support) (NP (DT the) (NN notion) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (CD _PROT2_))) (PP (IN with) (NP (NN _PROT_)))) (VP (VBZ results) (PP (IN in) (NP (NP (VBN enhanced) (NN tyrosine) (NN kinase) (NN activity)) (, ,) (NP (NN zeta) (NN chain) (NN phosphorylation)) (, ,) (CC and) (NP (NN T) (NN cell) (NN activation)))))))))) (. .)))
-1 #(S1 (S (NP (DT These) (NNS findings)) (ADVP (RB strongly)) (VP (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (MD may) (VP (VB be) (ADVP (RB closely)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN _PROT1_) (NN protein) (NN tyrosine) (NN phosphatase)) (PP (IN on) (NP (NN T) (NN cell) (NN surface))))))))))) (CC and) (VP (ADVP (RB further)) (VBP support) (NP (DT the) (NN notion) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (CD _PROT_))) (PP (IN with) (NP (NN _PROT2_)))) (VP (VBZ results) (PP (IN in) (NP (NP (VBN enhanced) (NN tyrosine) (NN kinase) (NN activity)) (, ,) (NP (NN zeta) (NN chain) (NN phosphorylation)) (, ,) (CC and) (NP (NN T) (NN cell) (NN activation)))))))))) (. .)))
+1 #(S1 (S (NP (DT These) (NNS findings)) (ADVP (RB strongly)) (VP (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (MD may) (VP (VB be) (ADVP (RB closely)) (VP (VBN associated) (PP (IN with) (NP (NP (DT the) (NN _PROT_) (NN protein) (NN tyrosine) (NN phosphatase)) (PP (IN on) (NP (NN T) (NN cell) (NN surface))))))))))) (CC and) (VP (ADVP (RB further)) (VBP support) (NP (DT the) (NN notion) (SBAR (IN that) (S (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (CD _PROT1_))) (PP (IN with) (NP (NN _PROT2_)))) (VP (VBZ results) (PP (IN in) (NP (NP (VBN enhanced) (NN tyrosine) (NN kinase) (NN activity)) (, ,) (NP (NN zeta) (NN chain) (NN phosphorylation)) (, ,) (CC and) (NP (NN T) (NN cell) (NN activation)))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (, ,) (NP (NP (DT a) (JJ desmosomal) (NN component)) (VP (VBG lacking) (NP (DT a) (NN transmembrane) (NN domain)))) (, ,)) (VP (VBZ has) (VP (VBN been) (VP (VBN implicated) (PP (IN in) (NP (DT this) (NN interaction))))) (, ,) (SBAR (IN although) (S (S (NP (JJS most) (NNS studies)) (VP (VBP have) (VP (VBN been) (VP (VBN conducted) (PP (IN with) (NP (NP (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP contain) (NP (NP (ADJP (JJ few))) (CC or) (NP (DT no)) (NP (NNS desmosomes)))))))))))) (, ,) (CC and) (S (NP (NP (NNS efforts)) (VP (TO to) (VP (VB demonstrate) (NP (NP (JJ direct) (NNS interactions)) (PP (IN between) (NP (NP (NN desmoplakin)) (CC and) (NP (JJ intermediate) (NNS filaments)))))))) (VP (VBP have) (RB not) (VP (VBN been) (ADJP (JJ successful))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ carboxy) (JJ terminal) (`` ``) (NN tail) (NN '')) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ associates) (ADVP (RB directly)) (PP (IN with) (NP (NP (DT the) (NN amino) (JJ terminal) (`` ``) (NN head) (NN '')) (PP (IN of) (NP (NP (NN type) (NN II) (JJ epidermal) (NNS keratins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))))))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ carboxy) (JJ terminal) (`` ``) (NN tail) (NN '')) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ associates) (ADVP (RB directly)) (PP (IN with) (NP (NP (DT the) (NN amino) (JJ terminal) (`` ``) (NN head) (NN '')) (PP (IN of) (NP (NP (NN type) (NN II) (JJ epidermal) (NNS keratins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))))))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ carboxy) (JJ terminal) (`` ``) (NN tail) (NN '')) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ associates) (ADVP (RB directly)) (PP (IN with) (NP (NP (DT the) (NN amino) (JJ terminal) (`` ``) (NN head) (NN '')) (PP (IN of) (NP (NP (NN type) (NN II) (JJ epidermal) (NNS keratins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))))))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ carboxy) (JJ terminal) (`` ``) (NN tail) (NN '')) (PP (IN of) (NP (NN _PROT1_)))) (VP (VBZ associates) (ADVP (RB directly)) (PP (IN with) (NP (NP (DT the) (NN amino) (JJ terminal) (`` ``) (NN head) (NN '')) (PP (IN of) (NP (NP (NN type) (NN II) (JJ epidermal) (NNS keratins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ carboxy) (JJ terminal) (`` ``) (NN tail) (NN '')) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ associates) (ADVP (RB directly)) (PP (IN with) (NP (NP (DT the) (NN amino) (JJ terminal) (`` ``) (NN head) (NN '')) (PP (IN of) (NP (NP (NN type) (NN II) (JJ epidermal) (NNS keratins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ carboxy) (JJ terminal) (`` ``) (NN tail) (NN '')) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ associates) (ADVP (RB directly)) (PP (IN with) (NP (NP (DT the) (NN amino) (JJ terminal) (`` ``) (NN head) (NN '')) (PP (IN of) (NP (NP (NN type) (NN II) (JJ epidermal) (NNS keratins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ carboxy) (JJ terminal) (`` ``) (NN tail) (NN '')) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ associates) (ADVP (RB directly)) (PP (IN with) (NP (NP (DT the) (NN amino) (JJ terminal) (`` ``) (NN head) (NN '')) (PP (IN of) (NP (NP (NN type) (NN II) (JJ epidermal) (NNS keratins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ carboxy) (JJ terminal) (`` ``) (NN tail) (NN '')) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ associates) (ADVP (RB directly)) (PP (IN with) (NP (NP (DT the) (NN amino) (JJ terminal) (`` ``) (NN head) (NN '')) (PP (IN of) (NP (NP (NN type) (NN II) (JJ epidermal) (NNS keratins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ carboxy) (JJ terminal) (`` ``) (NN tail) (NN '')) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ associates) (ADVP (RB directly)) (PP (IN with) (NP (NP (DT the) (NN amino) (JJ terminal) (`` ``) (NN head) (NN '')) (PP (IN of) (NP (NP (NN type) (NN II) (JJ epidermal) (NNS keratins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (JJ carboxy) (JJ terminal) (`` ``) (NN tail) (NN '')) (PP (IN of) (NP (NN _PROT_)))) (VP (VBZ associates) (ADVP (RB directly)) (PP (IN with) (NP (NP (DT the) (NN amino) (JJ terminal) (`` ``) (NN head) (NN '')) (PP (IN of) (NP (NP (NN type) (NN II) (JJ epidermal) (NNS keratins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_))))))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VP (VBN engineered)) (CC and) (VP (VBN purified) (NP (NP (JJ recombinant) (NN _PROT1_) (NN head)) (CC and) (NP (NN _PROT2_)) (NP (NN tail))))))) (, ,) (CC and) (S (NP (PRP we)) (VP (VBP demonstrate) (NP (JJ direct) (NN interaction)) (ADVP (FW in) (FW vitro)) (PP (PP (IN by) (NP (JJ solution-binding) (NNS assays))) (CC and) (PP (IN by) (NP (NN ligand) (NN blot) (NNS assays)))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN identified) (NP (NP (DT an) (JJ 18-amino) (NN acid) (NN residue) (NN stretch)) (PP (IN in) (NP (DT the) (NN _PROT1_) (NN head))) (SBAR (SBAR (WHNP (WDT that)) (S (VP (VBZ is) (VP (VBN conserved) (PP (ADVP (RB only)) (IN among) (NP (NN type) (NN II) (JJ epidermal) (NNS keratins))))))) (CC and) (SBAR (WHNP (WDT that)) (S (VP (VBZ appears) (S (VP (TO to) (VP (VB play) (NP (DT some) (NN role)) (PP (IN in) (NP (NN _PROT2_) (NN tail) (NN binding)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT A) (ADJP (RB newly) (VBN identified)) (NN member)) (PP (IN of) (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN receptor) (NN superfamily)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))))) (VP (VBZ suppresses) (NP (JJ _PROT2_) (NN apoptosis)))) (. .)))
-1 #(S1 (S (S (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT2_) (NN _PROT2_) (CD _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ new) (NN member)) (PP (IN of) (NP (DT the) (NN tumor) (NN necrosis) (NN factor) (NN receptor) (-LRB- -LRB-) (NN TNFR) (-RRB- -RRB-) (NN family)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_) (NN _PROT_) (CD _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ new) (NN member)) (PP (IN of) (NP (DT the) (NN tumor) (NN necrosis) (NN factor) (NN receptor) (-LRB- -LRB-) (NN TNFR) (-RRB- -RRB-) (NN family)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_) (NN _PROT1_) (CD _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ new) (NN member)) (PP (IN of) (NP (DT the) (NN tumor) (NN necrosis) (NN factor) (NN receptor) (-LRB- -LRB-) (NN TNFR) (-RRB- -RRB-) (NN family)))))) (. .)))
+1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
+1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_))) (: _PROT2_) (NP (NN _PROT2_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT2_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
+1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
+1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
+1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT1_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT2_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- _PROT2_) (NP (NN _PROT2_)) (-RRB- _PROT2_))) (: _PROT2_) (NP (NN _PROT2_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT2_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT2_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))) (: _PROT1_) (NP (NN _PROT1_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT2_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))) (: _PROT1_) (NP (NN _PROT1_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))) (: _PROT1_) (NP (NN _PROT1_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))) (: _PROT1_) (NP (NN _PROT1_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT2_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT1_AND_PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT1_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT1_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT2_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (: /) (NN _PROT_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_) (: /) (NN _PROT2_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (, ,) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN _PROT_)) (ADVP (RB specifically)) (VP (VBZ binds) (NP (NP (CD two) (JJ cellular) (NNS ligands)) (, ,) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (: _PROT_) (NP (NN _PROT_))) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_) (: /) (NN _PROT2_)) (-RRB- -RRB-)))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT1_)) (VP (VBD inhibited) (NP (NP (JJ _PROT2_) (NN cytotoxicity)) (PP (IN in) (NP (NN HT29) (NNS cells)))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT_) (: /) (NN _PROT_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT_) (: /) (NN _PROT_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT_) (: /) (NN _PROT_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT2_) (: /) (NN _PROT_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT_) (: /) (NN _PROT2_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT1_AND_PROT2_) (NN _PROT1_AND_PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT_) (: /) (NN _PROT_) (NNS receptors)))))))))))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT_) (: /) (NN _PROT_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT2_) (: /) (NN _PROT_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT_) (: /) (NN _PROT2_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT_) (: /) (NN _PROT_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT2_) (: /) (NN _PROT_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT_) (: /) (NN _PROT2_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT2_) (: /) (NN _PROT_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT_) (: /) (NN _PROT2_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBZ has) (VP (VBN been) (VP (VBN shown) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ triggers) (NP (NP (NN apoptosis)) (PP (IN of) (NP (NP (JJ various) (NN tumor) (NNS cells)) (PP (VBG including) (NP (NP (NN HT29) (NNS cells)) (SBAR (WHNP (WDT that)) (S (VP (VBP express) (NP (CC both) (NP (NP (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NN _PROT1_) (: /) (NN _PROT2_) (NNS receptors)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN with) (NP (NN _PROT_)))) (: /) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT2_)))) (: /) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_)))) (: /) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_)))) (: /) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_)))) (: /) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT2_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT2_)))) (: /) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT_)))) (: /) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT_)))) (: /) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT_)))) (: /) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT2_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT1_)))) (: /) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT1_)))) (: /) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT1_)))) (: /) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT2_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_)))) (: /) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_)))) (: /) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT2_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP$ Our) (NNS data)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ inhibits) (NP (NP (NP (DT the) (NNS interactions)) (PP (IN of) (NP (NN _PROT_))) (PP (IN with) (NP (NN _PROT_)))) (: /) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_)))) (, ,) (S (ADVP (RB thereby)) (VP (VBG suppressing) (NP (JJ _PROT2_) (NN HT29) (NN cell) (NN death))))))))) (. .)))
-1 #(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN _PROT1_)) (VP (MD may) (VP (VB play) (NP (DT a) (JJ regulatory) (NN role)) (PP (IN for) (S (VP (VBG suppressing) (PP (IN in) (NP (NP (NN _PROT2_)) (CC and) (NP (JJ _PROT_) (NN cell) (NN death)))))))))) (. .)))
-1 #(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN _PROT1_)) (VP (MD may) (VP (VB play) (NP (DT a) (JJ regulatory) (NN role)) (PP (IN for) (S (VP (VBG suppressing) (PP (IN in) (NP (NP (NN _PROT_)) (CC and) (NP (JJ _PROT2_) (NN cell) (NN death)))))))))) (. .)))
-1 #(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN _PROT_)) (VP (MD may) (VP (VB play) (NP (DT a) (JJ regulatory) (NN role)) (PP (IN for) (S (VP (VBG suppressing) (PP (IN in) (NP (NP (NN _PROT1_)) (CC and) (NP (JJ _PROT2_) (NN cell) (NN death)))))))))) (. .)))
-1 #(S1 (S (S (NP (JJ Multiple) (NNS proteins)) (ADVP (RB physically)) (VP (VBP interact) (PP (IN with) (S (VP (VBG _PROT1_) (NP (NP (JJ Transcriptional) (NN synergy)) (PP (IN with) (NP (NP (NN _PROT2_) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_) (NN _PROT_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-)))))))))) (. .)))
-1 #(S1 (S (S (NP (JJ Multiple) (NNS proteins)) (ADVP (RB physically)) (VP (VBP interact) (PP (IN with) (S (VP (VBG _PROT1_) (NP (NP (JJ Transcriptional) (NN synergy)) (PP (IN with) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-)))))))))) (. .)))
-1 #(S1 (S (S (NP (JJ Multiple) (NNS proteins)) (ADVP (RB physically)) (VP (VBP interact) (PP (IN with) (S (VP (VBG _PROT1_) (NP (NP (JJ Transcriptional) (NN synergy)) (PP (IN with) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_) (NN _PROT_)) (, ,) (NP (NN _PROT2_))) (-RRB- -RRB-)))))))))) (. .)))
-1 #(S1 (S (S (NP (JJ Multiple) (NNS proteins)) (ADVP (RB physically)) (VP (VBP interact) (PP (IN with) (S (VP (VBG _PROT_) (NP (NP (JJ Transcriptional) (NN synergy)) (PP (IN with) (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (NP (NN _PROT_))) (-RRB- -RRB-)))))))))) (. .)))
-1 #(S1 (S (S (NP (JJ Multiple) (NNS proteins)) (ADVP (RB physically)) (VP (VBP interact) (PP (IN with) (S (VP (VBG _PROT_) (NP (NP (JJ Transcriptional) (NN synergy)) (PP (IN with) (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_) (NN _PROT_)) (, ,) (NP (NN _PROT2_))) (-RRB- -RRB-)))))))))) (. .)))
-1 #(S1 (S (S (NP (JJ Multiple) (NNS proteins)) (ADVP (RB physically)) (VP (VBP interact) (PP (IN with) (S (VP (VBG _PROT_) (NP (NP (JJ Transcriptional) (NN synergy)) (PP (IN with) (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_) (NN _PROT1_)) (, ,) (NP (NN _PROT2_))) (-RRB- -RRB-)))))))))) (. .)))
-1 #(S1 (S (S (S (VP (VBG Using) (NP (VBN radiolabeled) (NN _PROT1_) (NN protein)) (PP (IN as) (NP (DT a) (NN probe))))) (, ,) (NP (PRP we)) (VP (VP (VBD screened) (NP (DT a) (NN B) (NN cell) (NN cDNA) (NN expression) (NN library))) (CC and) (VP (VBD isolated) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NP (NNS clones)) (VP (VBG encoding) (NP (NN _PROT2_) (NN interacting) (NNS proteins))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (CD Three)) (PP (IN of) (NP (DT these) (NNS clones)))) (VP (VBP encode) (NP (NP (NN DNA) (NN binding) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_) (NN _PROT1_)) (, ,) (NP (NN _PROT2_) (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))) (-RRB- -RRB-))) (, ,) (S (S (NP (CD one) (NN clone)) (VP (VBZ encodes) (NP (DT a) (NN chaperone) (NN protein)))) (, ,) (CC and) (S (NP (DT another) (NN clone)) (VP (VBZ encodes) (NP (DT a) (JJ multifunctional) (NN phosphatase))))))) (. .)))
-1 #(S1 (S (S (NP (NP (CD Three)) (PP (IN of) (NP (DT these) (NNS clones)))) (VP (VBP encode) (NP (NP (NN DNA) (NN binding) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_) (NN _PROT1_)) (, ,) (NP (NN _PROT_) (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))) (-RRB- -RRB-))) (, ,) (S (S (NP (CD one) (NN clone)) (VP (VBZ encodes) (NP (DT a) (NN chaperone) (NN protein)))) (, ,) (CC and) (S (NP (DT another) (NN clone)) (VP (VBZ encodes) (NP (DT a) (JJ multifunctional) (NN phosphatase))))))) (. .)))
-1 #(S1 (S (S (NP (NP (CD Three)) (PP (IN of) (NP (DT these) (NNS clones)))) (VP (VBP encode) (NP (NP (NN DNA) (NN binding) (NNS proteins)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT_) (NN _PROT_)) (, ,) (NP (NN _PROT1_) (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_))) (-RRB- -RRB-))) (, ,) (S (S (NP (CD one) (NN clone)) (VP (VBZ encodes) (NP (DT a) (NN chaperone) (NN protein)))) (, ,) (CC and) (S (NP (DT another) (NN clone)) (VP (VBZ encodes) (NP (DT a) (JJ multifunctional) (NN phosphatase))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN characterized) (NP (NP (DT the) (ADJP (ADJP (JJ physical)) (CC and) (ADJP (JJ functional))) (NNS interactions)) (PP (IN between) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))) (, ,) (NP (NP (DT a) (NP (NN leucine) (NN zipper)) (NN transcription) (NN factor)) (VP (VBN implicated) (PP (IN in) (NP (JJ inflammatory) (NNS responses))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NN deletion)) (PP (IN of) (NP (NP (DT the) (JJ carboxyl-terminal) (CD 28) (NN amino) (NNS acids)) (PP (IN of) (NP (NN _PROT1_)))))) (VP (VBD disrupted) (NP (NN _PROT2_) (NN _PROT_) (JJ physical) (NN interaction))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NN deletion)) (PP (IN of) (NP (NP (DT the) (JJ carboxyl-terminal) (CD 28) (NN amino) (NNS acids)) (PP (IN of) (NP (NN _PROT1_)))))) (VP (VBD disrupted) (NP (NN _PROT2_) (NN _PROT2_) (JJ physical) (NN interaction))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NN deletion)) (PP (IN of) (NP (NP (DT the) (JJ carboxyl-terminal) (CD 28) (NN amino) (NNS acids)) (PP (IN of) (NP (NN _PROT_)))))) (VP (VBD disrupted) (NP (NN _PROT1_AND_PROT2_) (NN _PROT2_) (JJ physical) (NN interaction))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (JJ transient) (NN expression) (NNS assays))) (, ,) (NP (PRP we)) (VP (VBD found) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))) (VP (MD can) (ADVP (RB functionally)) (VP (VB cooperate) (S (VP (TO to) (ADVP (RB synergistically)) (VP (VB activate) (NP (NN transcription))))))))))) (. .)))
-1 #(S1 (S (S (NP (JJ Electrophoretic) (NN mobility) (NN shift) (NNS assays)) (VP (VBD showed) (SBAR (IN that) (S (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))) (VP (MD can) (ADVP (RB simultaneously)) (VP (VB bind) (PP (TO to) (NP (JJ adjacent) (NN DNA) (NN binding) (NNS sites)))))) (, ,) (CC but) (S (ADVP (RB apparently)) (VP (VBP do) (RB not) (VP (VB influence) (NP (NP (DT the) (NP (NP (NN kinetics)) (CC or) (NP (NN affinity)))) (PP (IN of) (NP (NP (DT each) (JJ other) (POS 's)) (NN DNA) (NN binding))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (JJ transcriptional) (NN activity)) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN association)) (PP (IN with) (NP (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC or) (NP (NP (PRP$ its) (NNS relatives)) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (JJ transcriptional) (NN activity)) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN association)) (PP (IN with) (NP (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC or) (NP (NP (PRP$ its) (NNS relatives)) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (JJ transcriptional) (NN activity)) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN association)) (PP (IN with) (NP (NP (NP (DT the) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC or) (NP (NP (PRP$ its) (NNS relatives)) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (JJ transcriptional) (NN activity)) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN association)) (PP (IN with) (NP (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC or) (NP (NP (PRP$ its) (NNS relatives)) (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (JJ transcriptional) (NN activity)) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN association)) (PP (IN with) (NP (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC or) (NP (NP (PRP$ its) (NNS relatives)) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (JJ transcriptional) (NN activity)) (VP (VBZ is) (VP (VBN inhibited) (PP (IN by) (NP (NP (NN association)) (PP (IN with) (NP (NP (NP (DT the) (NN _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC or) (NP (NP (PRP$ its) (NNS relatives)) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))))))) (. .)))
-1 #(S1 (S (S (S (NP (NP (DT The) (JJ first) (NN cDNA)) (PP (IN from) (NP (DT the) (NN _PROT1_) (NN family))) (S (VP (TO to) (VP (VB be) (VP (VBN cloned)))))) (VP (VBD was) (VP (VBN designated) (S (NP (NN _PROT2_)))))) (, ,) (CC and) (S (NP (JJ multiple) (NN _PROT_) (NN family) (NNS members)) (VP (VBP have) (ADVP (RB now)) (VP (VBN been) (VP (VBN identified)))))) (. .)))
-1 #(S1 (S (S (S (NP (NP (DT The) (JJ first) (NN cDNA)) (PP (IN from) (NP (DT the) (NN _PROT1_) (NN family))) (S (VP (TO to) (VP (VB be) (VP (VBN cloned)))))) (VP (VBD was) (VP (VBN designated) (S (NP (NN _PROT_)))))) (, ,) (CC and) (S (NP (JJ multiple) (NN _PROT2_) (NN family) (NNS members)) (VP (VBP have) (ADVP (RB now)) (VP (VBN been) (VP (VBN identified)))))) (. .)))
-1 #(S1 (S (S (S (NP (NP (DT The) (JJ first) (NN cDNA)) (PP (IN from) (NP (DT the) (NN _PROT_) (NN family))) (S (VP (TO to) (VP (VB be) (VP (VBN cloned)))))) (VP (VBD was) (VP (VBN designated) (S (NP (NN _PROT1_)))))) (, ,) (CC and) (S (NP (JJ multiple) (NN _PROT2_) (NN family) (NNS members)) (VP (VBP have) (ADVP (RB now)) (VP (VBN been) (VP (VBN identified)))))) (. .)))
-1 #(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NN DP)) (VP (VBZ is) (ADVP (RB also)) (NP (NP (DT a) (NN family)) (PP (IN of) (NP (NP (NNS polypeptides)) (PP (IN with) (NP (NP (QP (IN at) (JJS least) (CD two)) (NNS members)) (PRN (-LRB- -LRB-) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (S (S (NP (CC Both) (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP bind) (PP (TO to) (NP (DT all) (NN _PROT_) (NN family) (NNS members))) (ADVP (FW in) (FW vivo)))) (, ,) (CC and) (S (NP (DT each) (NN complex)) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG activating) (NP (NN transcription))))))))) (. .)))
-1 #(S1 (S (S (S (NP (CC Both) (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VBP bind) (PP (TO to) (NP (DT all) (NN _PROT2_) (NN family) (NNS members))) (ADVP (FW in) (FW vivo)))) (, ,) (CC and) (S (NP (DT each) (NN complex)) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG activating) (NP (NN transcription))))))))) (. .)))
-1 #(S1 (S (S (S (NP (CC Both) (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VBP bind) (PP (TO to) (NP (DT all) (NN _PROT2_) (NN family) (NNS members))) (ADVP (FW in) (FW vivo)))) (, ,) (CC and) (S (NP (DT each) (NN complex)) (VP (VBZ is) (ADJP (JJ capable) (PP (IN of) (S (VP (VBG activating) (NP (NN transcription))))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT1_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT1_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT1_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT1_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT1_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT2_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT1_)) (CC or) (NP (NN _PROT2_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT1_)) (CC or) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT1_)) (CC or) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT1_)) (CC or) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT2_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT_)) (CC or) (NP (NN _PROT1_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT_)) (CC or) (NP (NN _PROT1_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT_)) (CC or) (NP (NN _PROT1_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT2_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC or) (NP (NN _PROT2_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT1_)) (CC or) (NP (NN _PROT_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT2_) (NN subunit))))))) (. .)))
-1 #(S1 (S (S (S (ADVP (RB However)) (, ,) (NP (DT the) (JJ various) (NN _PROT_) (NNS complexes)) (VP (VBP display) (NP (NP (JJ strong) (NNS differences)) (PP (IN in) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB bind) (PP (TO to) (NP (CC either) (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))) (ADVP (FW in) (FW vivo)))))))))) (, ,) (CC and) (S (NP (NP (DT the) (NN specificity)) (PP (IN of) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT1_)) (NP (NN binding))))) (VP (VBZ is) (VP (VBN mediated) (PP (IN by) (NP (DT the) (NN _PROT2_) (NN subunit))))))) (. .)))
+1 #(S1 (S (S (NP (NP (CD Two) (ADJP (ADJP (JJ distinct)) (CC and) (ADJP (JJ independent))) (NNS sites)) (PP (IN on) (NP (NN _PROT1_)))) (VP (VBP trigger) (NP (NP (NN _PROT2_) (CD _PROT2_) (NN dimer) (NN formation)) (CC and) (NP (NN signalling))))) (. .)))
+1 #(S1 (S (S (NP (NP (NP (NP (DT The) (JJ helical) (NN cytokine) (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))) (CD _PROT1_)) (CC and) (NP (PRP$ its) (JJ specific) (NN binding) (NN subunit) (NN _PROT2_) (NN _PROT2_))) (VP (VBP form) (NP (NP (DT a) (JJ 1:1) (NN complex)) (SBAR (WHNP (WDT which)) (S (, ,) (PP (IN by) (S (VP (VBG promoting) (NP (NP (NN homodimerization)) (PP (IN of) (NP (DT the) (NN signalling) (NN subunit) (NN _PROT_)))) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NN target) (NNS cells)))))))) (, ,) (VP (VBZ triggers) (NP (JJ intracellular) (NNS responses)))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NP (NP (DT The) (JJ helical) (NN cytokine) (NN _PROT1_)) (PRN (-LRB- _PROT1_) (NP (NN _PROT1_)) (-RRB- _PROT1_))) (CD _PROT1_)) (CC and) (NP (PRP$ its) (JJ specific) (NN binding) (NN subunit) (NN _PROT_) (NN _PROT_))) (VP (VBP form) (NP (NP (DT a) (JJ 1:1) (NN complex)) (SBAR (WHNP (WDT which)) (S (, ,) (PP (IN by) (S (VP (VBG promoting) (NP (NP (NN homodimerization)) (PP (IN of) (NP (DT the) (NN signalling) (NN subunit) (NN _PROT2_)))) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NN target) (NNS cells)))))))) (, ,) (VP (VBZ triggers) (NP (JJ intracellular) (NNS responses)))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NP (NP (DT The) (JJ helical) (NN cytokine) (NN _PROT_)) (PRN (-LRB- _PROT_) (NP (NN _PROT_)) (-RRB- _PROT_))) (CD _PROT_)) (CC and) (NP (PRP$ its) (JJ specific) (NN binding) (NN subunit) (NN _PROT1_) (NN _PROT1_))) (VP (VBP form) (NP (NP (DT a) (JJ 1:1) (NN complex)) (SBAR (WHNP (WDT which)) (S (, ,) (PP (IN by) (S (VP (VBG promoting) (NP (NP (NN homodimerization)) (PP (IN of) (NP (DT the) (NN signalling) (NN subunit) (NN _PROT2_)))) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (NN target) (NNS cells)))))))) (, ,) (VP (VBZ triggers) (NP (JJ intracellular) (NNS responses)))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VP (VBD expressed) (NP (NP (ADJP (RB differently) (VBN tagged)) (NNS forms)) (PP (IN of) (NP (NN _PROT1_))))) (CC and) (VP (VBD used) (NP (PRP them)) (PP (IN in) (NP (NP (JJ solution-phase) (NN binding) (NNS assays)) (VP (TO to) (VP (VB show) (SBAR (IN that) (S (NP (NP (DT the) (JJ soluble) (JJ extracellular) (NNS domains)) (PP (IN of) (NP (NN _PROT2_)))) (VP (VBP undergo) (NP (NN dimerization)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (NNS membranes))))))))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (ADVP (RB here)) (SBAR (IN that) (S (S (NP (NP (DT both) (NP (DT the) (NP (NN site) (CD 2)) (CC and) (NP (NN site) (CD 3))) (NN _PROT1_) (NNS variants)) (VP (VBN complexed) (PP (IN with) (NP (NN _PROT2_) (NN _PROT2_))))) (VP (VP (VBP bind) (NP (DT a) (JJ single) (NN _PROT_) (NN molecule))) (CC but) (VP (VBP are) (ADJP (JJ unable) (S (VP (TO to) (VP (VB dimerize) (NP (PRP it))))))))) (, ,) (IN whereas) (S (NP (DT the) (JJ combined) (NN site) (CD 2/3) (NNS variants)) (VP (VB lose) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT_))))))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (ADVP (RB here)) (SBAR (IN that) (S (S (NP (NP (DT both) (NP (DT the) (NP (NN site) (CD 2)) (CC and) (NP (NN site) (CD 3))) (NN _PROT1_) (NNS variants)) (VP (VBN complexed) (PP (IN with) (NP (NN _PROT_) (NN _PROT_))))) (VP (VP (VBP bind) (NP (DT a) (JJ single) (NN _PROT2_) (NN molecule))) (CC but) (VP (VBP are) (ADJP (JJ unable) (S (VP (TO to) (VP (VB dimerize) (NP (PRP it))))))))) (, ,) (IN whereas) (S (NP (DT the) (JJ combined) (NN site) (CD 2/3) (NNS variants)) (VP (VB lose) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (ADVP (RB here)) (SBAR (IN that) (S (S (NP (NP (DT both) (NP (DT the) (NP (NN site) (CD 2)) (CC and) (NP (NN site) (CD 3))) (NN _PROT1_) (NNS variants)) (VP (VBN complexed) (PP (IN with) (NP (NN _PROT_) (NN _PROT_))))) (VP (VP (VBP bind) (NP (DT a) (JJ single) (NN _PROT_) (NN molecule))) (CC but) (VP (VBP are) (ADJP (JJ unable) (S (VP (TO to) (VP (VB dimerize) (NP (PRP it))))))))) (, ,) (IN whereas) (S (NP (DT the) (JJ combined) (NN site) (CD 2/3) (NNS variants)) (VP (VB lose) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT2_))))))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (ADVP (RB here)) (SBAR (IN that) (S (S (NP (NP (DT both) (NP (DT the) (NP (NN site) (CD 2)) (CC and) (NP (NN site) (CD 3))) (NN _PROT_) (NNS variants)) (VP (VBN complexed) (PP (IN with) (NP (NN _PROT1_) (NN _PROT1_))))) (VP (VP (VBP bind) (NP (DT a) (JJ single) (NN _PROT2_) (NN molecule))) (CC but) (VP (VBP are) (ADJP (JJ unable) (S (VP (TO to) (VP (VB dimerize) (NP (PRP it))))))))) (, ,) (IN whereas) (S (NP (DT the) (JJ combined) (NN site) (CD 2/3) (NNS variants)) (VP (VB lose) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (ADVP (RB here)) (SBAR (IN that) (S (S (NP (NP (DT both) (NP (DT the) (NP (NN site) (CD 2)) (CC and) (NP (NN site) (CD 3))) (NN _PROT_) (NNS variants)) (VP (VBN complexed) (PP (IN with) (NP (NN _PROT1_) (NN _PROT1_))))) (VP (VP (VBP bind) (NP (DT a) (JJ single) (NN _PROT_) (NN molecule))) (CC but) (VP (VBP are) (ADJP (JJ unable) (S (VP (TO to) (VP (VB dimerize) (NP (PRP it))))))))) (, ,) (IN whereas) (S (NP (DT the) (JJ combined) (NN site) (CD 2/3) (NNS variants)) (VP (VB lose) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT2_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP demonstrate) (ADVP (RB here)) (SBAR (IN that) (S (S (NP (NP (DT both) (NP (DT the) (NP (NN site) (CD 2)) (CC and) (NP (NN site) (CD 3))) (NN _PROT_) (NNS variants)) (VP (VBN complexed) (PP (IN with) (NP (NN _PROT_) (NN _PROT_))))) (VP (VP (VBP bind) (NP (DT a) (JJ single) (NN _PROT1_) (NN molecule))) (CC but) (VP (VBP are) (ADJP (JJ unable) (S (VP (TO to) (VP (VB dimerize) (NP (PRP it))))))))) (, ,) (IN whereas) (S (NP (DT the) (JJ combined) (NN site) (CD 2/3) (NNS variants)) (VP (VB lose) (NP (DT the) (NN ability) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT2_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NP (DT The) (NN binding) (NNS properties)) (PP (IN of) (NP (DT these) (NNS variants))) (ADVP (FW in) (FW vitro))) (, ,) (CC and) (NP (NP (DT the) (NN result)) (PP (IN of) (S (VP (VBG using) (NP (NP (DT a) (VBG neutralizing) (JJ monoclonal) (NN antibody)) (VP (VBN directed) (PP (IN against) (NP (NN site) (CD 3))))))))) (, ,)) (VP (VBP lead) (PP (TO to) (NP (DT the) (NN conclusion) (SBAR (IN that) (S (NP (NN _PROT1_) (NN dimer)) (VP (VBZ is) (VP (VBN formed) (PP (IN through) (NP (NP (JJ direct) (NN binding)) (PP (IN at) (NP (NP (CD two) (ADJP (ADJP (JJ independent)) (CC and) (ADJP (RB differently) (VBN oriented))) (NNS sites)) (PP (IN on) (NP (NN _PROT2_))))))))))))))) (. .)))
+1 #(S1 (S (S (NP (NN Immunoprecipitation) (NNS experiments)) (ADVP (RB further)) (VP (VBP reveal) (SBAR (IN that) (S (NP (DT the) (ADJP (RB fully) (VBN assembled)) (NN receptor) (NN complex)) (VP (VBZ is) (VP (VBN composed) (PP (IN of) (NP (CD two) (NN _PROT1_) (, ,) (CD two) (NN _PROT2_) (NN _PROT2_) (CC and) (CD two) (NN _PROT_) (NNS molecules))))))))) (. .)))
+1 #(S1 (S (S (NP (NN Immunoprecipitation) (NNS experiments)) (ADVP (RB further)) (VP (VBP reveal) (SBAR (IN that) (S (NP (DT the) (ADJP (RB fully) (VBN assembled)) (NN receptor) (NN complex)) (VP (VBZ is) (VP (VBN composed) (PP (IN of) (NP (CD two) (NN _PROT1_) (, ,) (CD two) (NN _PROT_) (NN _PROT_) (CC and) (CD two) (NN _PROT2_) (NNS molecules))))))))) (. .)))
+1 #(S1 (S (S (NP (NN Immunoprecipitation) (NNS experiments)) (ADVP (RB further)) (VP (VBP reveal) (SBAR (IN that) (S (NP (DT the) (ADJP (RB fully) (VBN assembled)) (NN receptor) (NN complex)) (VP (VBZ is) (VP (VBN composed) (PP (IN of) (NP (CD two) (NN _PROT_) (, ,) (CD two) (NN _PROT1_) (NN _PROT1_) (CC and) (CD two) (NN _PROT2_) (NNS molecules))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (JJ Human) (NN spleen) (NN tyrosine) (NN kinase)) (NP (NN _PROT1_))) (VP (VBZ associates) (PP (IN with) (NP (NP (DT the) (NN Src-family) (NN kinase) (NN _PROT2_)) (CC and) (NP (DT a) (JJ _PROT_) (NN _PROT_)))))) (. .)))
+1 #(S1 (S (S (NP (NP (JJ Human) (NN spleen) (NN tyrosine) (NN kinase)) (NP (NN _PROT1_))) (VP (VBZ associates) (PP (IN with) (NP (NP (DT the) (NN Src-family) (NN kinase) (NN _PROT2_)) (CC and) (NP (DT a) (JJ _PROT_) (NN _PROT_)))))) (. .)))
+1 #(S1 (S (S (NP (NP (JJ Human) (NN spleen) (NN tyrosine) (NN kinase)) (NP (NN _PROT1_))) (VP (VBZ associates) (PP (IN with) (NP (NP (DT the) (NN Src-family) (NN kinase) (NN _PROT_)) (CC and) (NP (DT a) (JJ _PROT2_) (NN _PROT2_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (JJ Human) (NN spleen) (NN tyrosine) (NN kinase)) (NP (NN _PROT_))) (VP (VBZ associates) (PP (IN with) (NP (NP (DT the) (NN Src-family) (NN kinase) (NN _PROT1_AND_PROT2_)) (CC and) (NP (DT a) (JJ _PROT_) (NN _PROT_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (JJ Human) (NN spleen) (NN tyrosine) (NN kinase)) (NP (NN _PROT_))) (VP (VBZ associates) (PP (IN with) (NP (NP (DT the) (NN Src-family) (NN kinase) (NN _PROT1_)) (CC and) (NP (DT a) (JJ _PROT2_) (NN _PROT2_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (JJ Human) (NN spleen) (NN tyrosine) (NN kinase)) (NP (NN _PROT_))) (VP (VBZ associates) (PP (IN with) (NP (NP (DT the) (NN Src-family) (NN kinase) (NN _PROT1_)) (CC and) (NP (DT a) (JJ _PROT2_) (NN _PROT2_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ 72-kDa) (NN spleen) (NN tyrosine) (NN kinase) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-)) (CC and) (NP (NN Src-family) (NN kinase) (NN _PROT2_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP contribute) (PP (TO to) (NP (NP (NN signaling)) (PP (IN via) (NP (DT the) (NN B-cell) (NN antigen) (NN receptor) (NN complex))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ 72-kDa) (NN spleen) (NN tyrosine) (NN kinase) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-)) (CC and) (NP (NN Src-family) (NN kinase) (NN _PROT2_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP contribute) (PP (TO to) (NP (NP (NN signaling)) (PP (IN via) (NP (DT the) (NN B-cell) (NN antigen) (NN receptor) (NN complex))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ 72-kDa) (NN spleen) (NN tyrosine) (NN kinase) (-LRB- -LRB-) (NN _PROT1_) (-RRB- -RRB-)) (CC and) (NP (NN Src-family) (NN kinase) (NN _PROT_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-))) (VP (VBP contribute) (PP (TO to) (NP (NP (NN signaling)) (PP (IN via) (NP (DT the) (NN B-cell) (NN antigen) (NN receptor) (NN complex))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ 72-kDa) (NN spleen) (NN tyrosine) (NN kinase) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (CC and) (NP (NN Src-family) (NN kinase) (NN _PROT1_AND_PROT2_) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-))) (VP (VBP contribute) (PP (TO to) (NP (NP (NN signaling)) (PP (IN via) (NP (DT the) (NN B-cell) (NN antigen) (NN receptor) (NN complex))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ 72-kDa) (NN spleen) (NN tyrosine) (NN kinase) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (CC and) (NP (NN Src-family) (NN kinase) (NN _PROT1_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-))) (VP (VBP contribute) (PP (TO to) (NP (NP (NN signaling)) (PP (IN via) (NP (DT the) (NN B-cell) (NN antigen) (NN receptor) (NN complex))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ 72-kDa) (NN spleen) (NN tyrosine) (NN kinase) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-)) (CC and) (NP (NN Src-family) (NN kinase) (NN _PROT1_) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-))) (VP (VBP contribute) (PP (TO to) (NP (NP (NN signaling)) (PP (IN via) (NP (DT the) (NN B-cell) (NN antigen) (NN receptor) (NN complex))))))) (. .)))
+1 #(S1 (S (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (PP (IN from) (NP (JJ human) (NN B) (NNS lymphocytes)))) (VP (MD can) (VP (VB interact) (ADVP (RB directly)))))))) (. .)))
+1 #(S1 (S (S (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBD coimmunoprecipitated) (PP (IN from) (NP (ADJP (ADJP (JJ mature)) (CC and) (ADJP (JJ activated))) (NN B-cell) (NNS lines))))) (, ,) (CC and) (S (NP (NP (JJ gel-purified) (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VBD reassociated) (PP (IN in) (NP (FW vitro))) (, ,) (S (VP (VBG demonstrating) (NP (PRP$ their) (JJ direct) (NN interaction))))))) (. .)))
-1 #(S1 (S (S (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VBD coimmunoprecipitated) (PP (IN from) (NP (ADJP (ADJP (JJ mature)) (CC and) (ADJP (JJ activated))) (NN B-cell) (NNS lines))))) (, ,) (CC and) (S (NP (NP (JJ gel-purified) (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBD reassociated) (PP (IN in) (NP (FW vitro))) (, ,) (S (VP (VBG demonstrating) (NP (PRP$ their) (JJ direct) (NN interaction))))))) (. .)))
-1 #(S1 (S (S (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VBD coimmunoprecipitated) (PP (IN from) (NP (ADJP (ADJP (JJ mature)) (CC and) (ADJP (JJ activated))) (NN B-cell) (NNS lines))))) (, ,) (CC and) (S (NP (NP (JJ gel-purified) (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBD reassociated) (PP (IN in) (NP (FW vitro))) (, ,) (S (VP (VBG demonstrating) (NP (PRP$ their) (JJ direct) (NN interaction))))))) (. .)))
-1 #(S1 (S (S (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VBD coimmunoprecipitated) (PP (IN from) (NP (ADJP (ADJP (JJ mature)) (CC and) (ADJP (JJ activated))) (NN B-cell) (NNS lines))))) (, ,) (CC and) (S (NP (NP (JJ gel-purified) (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (VP (VBD reassociated) (PP (IN in) (NP (FW vitro))) (, ,) (S (VP (VBG demonstrating) (NP (PRP$ their) (JJ direct) (NN interaction))))))) (. .)))
-1 #(S1 (S (S (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VBD coimmunoprecipitated) (PP (IN from) (NP (ADJP (ADJP (JJ mature)) (CC and) (ADJP (JJ activated))) (NN B-cell) (NNS lines))))) (, ,) (CC and) (S (NP (NP (JJ gel-purified) (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (VP (VBD reassociated) (PP (IN in) (NP (FW vitro))) (, ,) (S (VP (VBG demonstrating) (NP (PRP$ their) (JJ direct) (NN interaction))))))) (. .)))
+1 #(S1 (S (S (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (VP (VBD coimmunoprecipitated) (PP (IN from) (NP (ADJP (ADJP (JJ mature)) (CC and) (ADJP (JJ activated))) (NN B-cell) (NNS lines))))) (, ,) (CC and) (S (NP (NP (JJ gel-purified) (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBD reassociated) (PP (IN in) (NP (FW vitro))) (, ,) (S (VP (VBG demonstrating) (NP (PRP$ their) (JJ direct) (NN interaction))))))) (. .)))
+1 #(S1 (S (S (NP (DT This) (NN _PROT1_AND_PROT2_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT1_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT2_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT1_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT2_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT1_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT2_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT1_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT2_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT1_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT2_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT1_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT2_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT1_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT2_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT1_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT2_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
+1 #(S1 (S (S (NP (DT This) (NN _PROT_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT1_AND_PROT2_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT1_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT2_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT1_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT2_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT1_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT2_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT1_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT2_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This) (NN _PROT_) (NN interaction)) (VP (MD may) (VP (VB be) (ADJP (JJ dependent) (PP (IN on) (NP (NP (DT the) (NN stage)) (PP (IN of) (NP (NN B-cell) (NN differentiation)))))) (, ,) (SBAR (IN since) (S (S (NP (NN _PROT_) (NNS associations)) (VP (VBD were) (RB not) (VP (VBN detected) (PP (IN in) (NP (NP (NN pre-B)) (CC and) (NP (NN myeloma) (NN cell) (NNS lines))))))) (CC and) (S (NP (NP (NN _PROT1_)) (PP (IN from) (NP (DT an) (JJ immature) (NN B-cell) (NN line)))) (VP (VBD did) (RB not) (VP (VB reassociate) (PP (IN with) (NP (NN _PROT2_))) (ADVP (FW in) (FW vitro)))))))))) (. .)))
-1 #(S1 (S (NP (NP (NN Crosslinking)) (PP (IN of) (NP (NN cell) (NN surface) (NP (NN IgM))))) (VP (VBD led) (PP (TO to) (NP (NP (JJ rapid) (NN activation)) (PP (IN of) (NP (NP (DT both) (NP (NN tyrosine) (CC and) (NN serine/threonine) (NN protein) (NN kinase)) (NNS activities)) (SBAR (WHNP (WDT that)) (S (VP (VBD resulted) (PP (IN in) (NP (NN phosphorylation))) (ADVP (FW in) (FW vitro))))))) (PP (IN of) (NP (NP (NNS proteins)) (ADJP (JJ coprecipitating) (PP (IN with) (NP (NP (NN _PROT1_) (JJ particular)) (, ,) (NP (NP (DT a) (NN serine/threonine) (JJ phosphorylated) (NN protein) (CD 120) (NN kDa)) (PP (IN in) (NP (NP (NN size)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (JJ Several) (NNS phosphoproteins)) (, ,) (PP (VBG including) (NP (NP (NP (CD one)) (PP (IN of) (NP (CD 72) (NN kDa)))) (CC and) (NP (NP (CD one)) (PP (IN of) (NP (CD 120) (NN kDa)))))) (, ,)) (VP (VBD coprecipitated) (PP (IN with) (NP (NP (NN _PROT1_) (NN _PROT1_) (CD _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (NN _PROT2_) (CD _PROT2_)) (-RRB- -RRB-)))))) (. .)))
+1 #(S1 (S (S (NP (JJ Sequential) (NN immunoprecipitation)) (VP (VBD identified) (NP (NP (DT the) (JJ 72-kDa) (NN protein)) (VP (VBN associated) (PP (IN with) (NP (NN _PROT1_) (NN _PROT1_) (CD _PROT1_))))) (PP (IN as) (NP (NN _PROT2_))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ 120-kDa) (NN serine/threonine) (JJ phosphorylated) (NN protein)) (SBAR (WHNP (WDT that)) (S (VP (VBD coprecipitated) (PP (IN with) (NP (NN _PROT1_) (NN _PROT1_) (CD _PROT1_))))))) (VP (VBD resembled) (NP (NP (DT the) (JJ _PROT2_) (NN _PROT_)) (PP (IN by) (NP (JJ several) (NNS criteria)))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ 120-kDa) (NN serine/threonine) (JJ phosphorylated) (NN protein)) (SBAR (WHNP (WDT that)) (S (VP (VBD coprecipitated) (PP (IN with) (NP (NN _PROT1_) (NN _PROT1_) (CD _PROT1_))))))) (VP (VBD resembled) (NP (NP (DT the) (JJ _PROT_) (NN _PROT2_)) (PP (IN by) (NP (JJ several) (NNS criteria)))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (JJ 120-kDa) (NN serine/threonine) (JJ phosphorylated) (NN protein)) (SBAR (WHNP (WDT that)) (S (VP (VBD coprecipitated) (PP (IN with) (NP (NN _PROT_) (NN _PROT_) (CD _PROT_))))))) (VP (VBD resembled) (NP (NP (DT the) (JJ _PROT1_) (NN _PROT2_)) (PP (IN by) (NP (JJ several) (NNS criteria)))))) (. .)))
+1 #(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN _PROT1_)) (VP (MD may) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (NN link)) (PP (IN between) (NP (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_) (NN _PROT_) (CD _PROT_))) (, ,) (NP (NP (NN coupling)) (NP (DT the) (NN B-cell) (NN antigen) (NN receptor)) (PP (TO to) (NP (DT the) (NN phosphatidylinositol) (NN pathway))))))))))) (. .)))
+1 #(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN _PROT1_)) (VP (MD may) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (NN link)) (PP (IN between) (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_) (CD _PROT2_))) (, ,) (NP (NP (NN coupling)) (NP (DT the) (NN B-cell) (NN antigen) (NN receptor)) (PP (TO to) (NP (DT the) (NN phosphatidylinositol) (NN pathway))))))))))) (. .)))
+1 #(S1 (S (S (ADVP (RB Thus)) (, ,) (NP (NN _PROT_)) (VP (MD may) (VP (VB serve) (PP (IN as) (NP (NP (DT a) (NN link)) (PP (IN between) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_) (CD _PROT2_))) (, ,) (NP (NP (NN coupling)) (NP (DT the) (NN B-cell) (NN antigen) (NN receptor)) (PP (TO to) (NP (DT the) (NN phosphatidylinositol) (NN pathway))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (JJ Specific) (NN binding)) (PP (IN of) (NP (NP (DT the) (NN transglutaminase)) (, ,) (NP (NN _PROT1_) (NN _PROT1_) (CD _PROT1_)) (, ,))) (PP (TO to) (NP (NN _PROT2_))))) (. .)))
-1 #(S1 (S (S (ADVP (RB However)) (, ,) (NP (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NN _PROT1_)))) (CC and) (NP (NP (DT the) (NN identity)) (PP (IN of) (NP (NP (NNS proteins)) (SBAR (WHNP (WDT that)) (S (VP (VBP interact) (PP (IN with) (NP (NN _PROT2_)))))))))) (VP (VBP remain) (ADJP (JJ unknown)))) (. .)))
-1 #(S1 (S (S (S (VP (TO To) (VP (VB identify) (NP (JJ specific) (JJ _PROT1_) (NNS interactions))))) (, ,) (NP (NP (DT a) (JJ recombinant) (NN fusion) (NN protein)) (NP (NN affinity) (NN reagent))) (VP (VBD was) (VP (VP (VBN constructed)) (CC and) (VP (VBN used) (S (VP (TO to) (VP (VB identify) (NP (NP (NNS proteins)) (VP (VBG associating) (PP (IN with) (NP (NN _PROT2_))) (PP (IN from) (NP (NP (JJ human) (NN platelet) (NNS lysates)) (CC and) (NP (NN erythroleukemia) (NNS cells))))))))))))) (. .)))
+1 #(S1 (S (S (NP (NN Immunoblotting) (NNS studies)) (VP (VBD were) (VP (VBN used) (S (VP (TO to) (VP (VB confirm) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN from) (NP (JJ fresh) (NN platelet) (NNS lysates))) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN fusion) (NN protein)))))))))) (. .)))
+1 #(S1 (S (S (NP (NN _PROT1_)) (ADVP (RB also)) (VP (VBD was) (VP (VBN shown) (S (VP (VP (TO to) (VP (VBP coprecipitate) (PP (IN with) (NP (NN _PROT2_))) (PP (IN in) (NP (NN immunoprecipitation) (NNS studies))))) (CC and) (VP (TO to) (VP (VB colocalize) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (NP (NN immunofluorescence) (NNS studies)) (PP (IN of) (NP (JJ intact) (JJ glass-activated) (NNS platelets)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT1_)) (ADVP (RB also)) (VP (VBD was) (VP (VBN shown) (S (VP (VP (TO to) (VP (VBP coprecipitate) (PP (IN with) (NP (NN _PROT_))) (PP (IN in) (NP (NN immunoprecipitation) (NNS studies))))) (CC and) (VP (TO to) (VP (VB colocalize) (PP (IN with) (NP (NN _PROT2_))) (PP (IN in) (NP (NP (NN immunofluorescence) (NNS studies)) (PP (IN of) (NP (JJ intact) (JJ glass-activated) (NNS platelets)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT_)) (ADVP (RB also)) (VP (VBD was) (VP (VBN shown) (S (VP (VP (TO to) (VP (VBP coprecipitate) (PP (IN with) (NP (NN _PROT1_))) (PP (IN in) (NP (NN immunoprecipitation) (NNS studies))))) (CC and) (VP (TO to) (VP (VB colocalize) (PP (IN with) (NP (NN _PROT2_))) (PP (IN in) (NP (NP (NN immunofluorescence) (NNS studies)) (PP (IN of) (NP (JJ intact) (JJ glass-activated) (NNS platelets)))))))))))) (. .)))
+1 #(S1 (S (S (NP (DT The) (NNS data)) (ADVP (RB thus)) (VP (VP (VBP demonstrate) (NP (NP (JJ specific) (NN binding)) (PP (IN of) (NP (NN platelet) (NN _PROT1_))) (PP (TO to) (NP (NN _PROT2_))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (NP (JJ cellular) (NN localization)) (CC and/or) (NP (JJ enzymatic) (NN regulation))) (PP (IN of) (NP (NN platelet) (NN _PROT_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (NNS data)) (ADVP (RB thus)) (VP (VP (VBP demonstrate) (NP (NP (JJ specific) (NN binding)) (PP (IN of) (NP (NN platelet) (NN _PROT1_))) (PP (TO to) (NP (NN _PROT_))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (NP (JJ cellular) (NN localization)) (CC and/or) (NP (JJ enzymatic) (NN regulation))) (PP (IN of) (NP (NN platelet) (NN _PROT_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (NNS data)) (ADVP (RB thus)) (VP (VP (VBP demonstrate) (NP (NP (JJ specific) (NN binding)) (PP (IN of) (NP (NN platelet) (NN _PROT1_))) (PP (TO to) (NP (NN _PROT_))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (NP (JJ cellular) (NN localization)) (CC and/or) (NP (JJ enzymatic) (NN regulation))) (PP (IN of) (NP (NN platelet) (NN _PROT2_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (NNS data)) (ADVP (RB thus)) (VP (VP (VBP demonstrate) (NP (NP (JJ specific) (NN binding)) (PP (IN of) (NP (NN platelet) (NN _PROT_))) (PP (TO to) (NP (NN _PROT1_))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (NP (JJ cellular) (NN localization)) (CC and/or) (NP (JJ enzymatic) (NN regulation))) (PP (IN of) (NP (NN platelet) (NN _PROT_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (NNS data)) (ADVP (RB thus)) (VP (VP (VBP demonstrate) (NP (NP (JJ specific) (NN binding)) (PP (IN of) (NP (NN platelet) (NN _PROT_))) (PP (TO to) (NP (NN _PROT1_))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (NP (JJ cellular) (NN localization)) (CC and/or) (NP (JJ enzymatic) (NN regulation))) (PP (IN of) (NP (NN platelet) (NN _PROT2_)))))))))))) (. .)))
+1 #(S1 (S (S (NP (DT The) (NNS data)) (ADVP (RB thus)) (VP (VP (VBP demonstrate) (NP (NP (JJ specific) (NN binding)) (PP (IN of) (NP (NN platelet) (NN _PROT_))) (PP (TO to) (NP (NN _PROT_))))) (CC and) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (MD may) (VP (VB participate) (PP (IN in) (NP (NP (DT the) (NP (JJ cellular) (NN localization)) (CC and/or) (NP (JJ enzymatic) (NN regulation))) (PP (IN of) (NP (NN platelet) (NN _PROT2_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN X-ray) (NN structure)) (PP (IN of) (NP (DT a) (NN _PROT1_) (NN _PROT1_AND_PROT2_) (NN receptor) (NN complex))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ human) (NN pituitary) (NNS hormones)) (, ,) (NP (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP regulate) (NP (NP (DT a) (JJ large) (NN variety)) (PP (IN of) (NP (JJ physiological) (NNS processes))) (, ,) (SBAR (WHPP (IN among) (WHNP (WDT which))) (S (VP (VBP are) (NP (NP (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (NP (NN muscle)) (, ,) (NP (NP (NP (NN bone)) (CC and) (NP (NN cartilage))) (NNS cells)) (, ,) (CC and) (NP (NN lactation))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ human) (NN pituitary) (NNS hormones)) (, ,) (NP (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP regulate) (NP (NP (DT a) (JJ large) (NN variety)) (PP (IN of) (NP (JJ physiological) (NNS processes))) (, ,) (SBAR (WHPP (IN among) (WHNP (WDT which))) (S (VP (VBP are) (NP (NP (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (NP (NN muscle)) (, ,) (NP (NP (NP (NN bone)) (CC and) (NP (NN cartilage))) (NNS cells)) (, ,) (CC and) (NP (NN lactation))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ human) (NN pituitary) (NNS hormones)) (, ,) (NP (NP (NP (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP regulate) (NP (NP (DT a) (JJ large) (NN variety)) (PP (IN of) (NP (JJ physiological) (NNS processes))) (, ,) (SBAR (WHPP (IN among) (WHNP (WDT which))) (S (VP (VBP are) (NP (NP (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (NP (NN muscle)) (, ,) (NP (NP (NP (NN bone)) (CC and) (NP (NN cartilage))) (NNS cells)) (, ,) (CC and) (NP (NN lactation))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ human) (NN pituitary) (NNS hormones)) (, ,) (NP (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP regulate) (NP (NP (DT a) (JJ large) (NN variety)) (PP (IN of) (NP (JJ physiological) (NNS processes))) (, ,) (SBAR (WHPP (IN among) (WHNP (WDT which))) (S (VP (VBP are) (NP (NP (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (NP (NN muscle)) (, ,) (NP (NP (NP (NN bone)) (CC and) (NP (NN cartilage))) (NNS cells)) (, ,) (CC and) (NP (NN lactation))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ human) (NN pituitary) (NNS hormones)) (, ,) (NP (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP regulate) (NP (NP (DT a) (JJ large) (NN variety)) (PP (IN of) (NP (JJ physiological) (NNS processes))) (, ,) (SBAR (WHPP (IN among) (WHNP (WDT which))) (S (VP (VBP are) (NP (NP (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (NP (NN muscle)) (, ,) (NP (NP (NP (NN bone)) (CC and) (NP (NN cartilage))) (NNS cells)) (, ,) (CC and) (NP (NN lactation))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ human) (NN pituitary) (NNS hormones)) (, ,) (NP (NP (NP (NN _PROT_) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-)))) (, ,)) (VP (VBP regulate) (NP (NP (DT a) (JJ large) (NN variety)) (PP (IN of) (NP (JJ physiological) (NNS processes))) (, ,) (SBAR (WHPP (IN among) (WHNP (WDT which))) (S (VP (VBP are) (NP (NP (NP (NN growth)) (CC and) (NP (NN differentiation))) (PP (IN of) (NP (NP (NN muscle)) (, ,) (NP (NP (NP (NN bone)) (CC and) (NP (NN cartilage))) (NNS cells)) (, ,) (CC and) (NP (NN lactation))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (NN single-pass) (NN transmembrane) (NNS receptors)) (PP (IN from) (NP (NP (NN class) (CD 1)) (PP (IN of) (NP (DT the) (JJ haematopoietic) (NN receptor) (NN superfamily)))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (NN single-pass) (NN transmembrane) (NNS receptors)) (PP (IN from) (NP (NP (NN class) (CD 1)) (PP (IN of) (NP (DT the) (JJ haematopoietic) (NN receptor) (NN superfamily)))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (NN single-pass) (NN transmembrane) (NNS receptors)) (PP (IN from) (NP (NP (NN class) (CD 1)) (PP (IN of) (NP (DT the) (JJ haematopoietic) (NN receptor) (NN superfamily)))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (NN single-pass) (NN transmembrane) (NNS receptors)) (PP (IN from) (NP (NP (NN class) (CD 1)) (PP (IN of) (NP (DT the) (JJ haematopoietic) (NN receptor) (NN superfamily)))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (NN single-pass) (NN transmembrane) (NNS receptors)) (PP (IN from) (NP (NP (NN class) (CD 1)) (PP (IN of) (NP (DT the) (JJ haematopoietic) (NN receptor) (NN superfamily)))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))) (NNS receptors)) (PRN (-LRB- -LRB-) (NP (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (, ,) (ADVP (RB respectively))) (-RRB- -RRB-))) (VP (VBP are) (NP (NP (NN single-pass) (NN transmembrane) (NNS receptors)) (PP (IN from) (NP (NP (NN class) (CD 1)) (PP (IN of) (NP (DT the) (JJ haematopoietic) (NN receptor) (NN superfamily)))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT1_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT2_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT1_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT1_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT2_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT1_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT1_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT1_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT2_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT1_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT1_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT2_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT1_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT1_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT1_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT2_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT1_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT2_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT1_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT1_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT1_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT2_)))) (VP (VBP overlap))))))) (. .)))
+1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT1_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
+1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT1_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT1_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT2_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT2_)))) (VP (VBP overlap))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (DT the) (NN case)) (PP (IN of) (NP (NN _PROT_))))) (, ,) (NP (NN activation)) (VP (VBZ involves) (NP (NN receptor) (NN homodimerization)) (PP (IN in) (NP (DT a) (JJ sequential) (NN process))))) (: :) (S (NP (NP (DT the) (JJ active) (JJ ternary) (NN complex)) (VP (VBG containing) (NP (NP (CD one) (NN ligand)) (CC and) (NP (CD two) (NN receptor) (NNS molecules))))) (VP (VBZ is) (VP (VBN formed) (PP (IN by) (S (S (NP (NP (NN association)) (PP (IN of) (NP (DT a) (NN receptor) (NN molecule))) (PP (TO to) (NP (DT an) (JJ intermediate) (NN 1:1) (NN complex.) (NN _PROT_)))) (VP (VBZ does) (RB not) (VP (VB bind) (PP (TO to) (NP (DT the) (NN _PROT_) (NN receptor)))))) (, ,) (CC but) (S (NP (NN _PROT_)) (VP (VBZ binds) (PP (TO to) (NP (CC both) (DT the) (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))))))))) (, ,) (CC and) (S (NP (NN mutagenesis) (NNS studies)) (VP (VBP have) (VP (VBN shown) (SBAR (IN that) (S (NP (NP (DT the) (JJ receptor-binding) (NNS sites)) (PP (IN on) (NP (NN _PROT2_)))) (VP (VBP overlap))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP present) (ADVP (RB here)) (NP (NP (DT the) (NN crystal) (NN structure)) (PP (IN of) (NP (NP (DT the) (JJ 1:1) (NN complex)) (PP (IN of) (NP (NP (NN _PROT1_)) (VP (VBD bound) (PP (TO to) (NP (NP (DT the) (JJ extracellular) (NN domain)) (PP (IN of) (NP (DT the) (NN _PROT2_))))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (NNS Comparisons)) (PP (IN with) (NP (DT the) (NN _PROT1_AND_PROT2_) (NN complex)))) (VP (VBP reveal) (SBAR (WHADVP (WRB how)) (S (NP (NN _PROT_)) (VP (MD can) (VP (VB bind) (PP (TO to) (NP (DT the) (CD two) (ADJP (RB distinctly) (JJ different)) (NN receptor) (NN binding) (NNS surfaces))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NNS Comparisons)) (PP (IN with) (NP (DT the) (NN _PROT1_) (NN complex)))) (VP (VBP reveal) (SBAR (WHADVP (WRB how)) (S (NP (NN _PROT2_)) (VP (MD can) (VP (VB bind) (PP (TO to) (NP (DT the) (CD two) (ADJP (RB distinctly) (JJ different)) (NN receptor) (NN binding) (NNS surfaces))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NNS Comparisons)) (PP (IN with) (NP (DT the) (NN _PROT1_) (NN complex)))) (VP (VBP reveal) (SBAR (WHADVP (WRB how)) (S (NP (NN _PROT2_)) (VP (MD can) (VP (VB bind) (PP (TO to) (NP (DT the) (CD two) (ADJP (RB distinctly) (JJ different)) (NN receptor) (NN binding) (NNS surfaces))))))))) (. .)))
-1 #(S1 (S (NP (NN _PROT1_)) (VP (VBZ _PROT1_) (NP (NP (DT an) (JJ Ala-->Gly) (NN substitution)) (PP (IN in) (NP (NP (NN helix) (CD 1)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_) (NN repeat) (CD 17))))) (SBAR (WHNP (WDT that)) (S (ADVP (RB severely)) (VP (VBZ disrupts) (NP (NP (DT the) (NP (NN structure)) (CC and) (NP (NN self-association))) (PP (IN of) (NP (DT the) (NN erythrocyte) (NN spectrin) (NN heterodimer))))))))) (. .)))
+1 #(S1 (S (NP (DT The) (NN self-association) (NN site)) (VP (VBZ appears) (S (VP (TO to) (VP (VB be) (VP (VBN formed) (PP (IN by) (NP (NP (NNS interactions)) (PP (IN between) (NP (NP (NNS helices) (CD 1) (CC and) (CD 2)) (PP (IN of) (NP (NP (NN _PROT1_) (NN _PROT1_) (NN repeat) (CD 17)) (PP (IN of) (NP (NP (CD one) (NN dimer)) (PP (IN with) (NP (NP (NN helix) (CD 3)) (PP (IN of) (NP (NP (NN _PROT2_) (NN _PROT2_) (NN repeat) (CD 1)) (PP (IN of) (NP (DT the) (JJ other) (NN dimer))) (S (VP (TO to) (VP (VB form) (NP (CD two) (JJ combined) (NN alpha-beta) (JJ triple-helical) (NNS segments)))))))))))))))))))))) (. .)))
-1 #(S1 (S (S (PP (VBG Following) (NP (NP (NN linkage) (NNS studies)) (SBAR (WHNP (WDT which)) (S (VP (VBD were) (ADJP (RBS most) (JJ consistent) (PP (IN with) (NP (DT a) (NN _PROT1_) (NN _PROT1_) (NN gene) (NN mutation))))))))) (, ,) (NP (DT a) (NN nucleotide) (NN change)) (VP (VBD was) (VP (VBN identified) (PP (IN in) (NP (NN codon) (CD 2018))) (, ,) (S (VP (VBG resulting) (PP (IN in) (NP (NP (DT an) (JJ Ala-->Gly) (NN substitution)) (PP (IN in) (NP (NP (DT the) (JJ first) (JJ helical) (NN domain)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_) (NP (NN repeat) (CD 17))))))))))))) (. .)))
-1 #(S1 (S (NP (NP (NN Involvement)) (PP (IN of) (NP (NN _PROT1_) (NN signal) (NN transducer) (NN _PROT2_))) (PP (IN in) (NP (JJ _PROT_) (NN signal) (NN transduction))) (. .))))
-1 #(S1 (S (NP (NP (NN Involvement)) (PP (IN of) (NP (NN _PROT1_) (NN signal) (NN transducer) (NN _PROT_))) (PP (IN in) (NP (JJ _PROT2_) (NN signal) (NN transduction))) (. .))))
-1 #(S1 (S (NP (NP (NN Involvement)) (PP (IN of) (NP (NN _PROT_) (NN signal) (NN transducer) (NN _PROT1_))) (PP (IN in) (NP (JJ _PROT2_) (NN signal) (NN transduction))) (. .))))
-1 #(S1 (S (S (NP (NN _PROT1_)) (VP (VBZ is) (NP (NP (DT a) (JJ novel) (NN cytokine)) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NP (NNS biofunctions)) (SBAR (WHNP (WDT which)) (S (VP (VBP overlap) (PP (IN with) (NP (NP (DT those)) (PP (IN of) (NP (NN _PROT2_))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP have) (ADVP (RB previously)) (VP (VBN identified) (NP (NP (NN _PROT1_) (JJ specific) (NN binding) (NN protein)) (SBAR (WHNP (WDT which)) (S (VP (VBZ is) (ADJP (JJ distinct) (PP (IN from) (NP (NP (DT that)) (PP (IN of) (NP (NP (NN _PROT2_)) (PP (IN in) (NP (NP (DT a) (NN number)) (PP (IN of) (NP (NN cell) (NNS lines))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NP (NP (DT The) (NNS similarities)) (PP (IN in) (NP (NNS biofunctions)))) (CC and) (NP (NP (NNS differences)) (PP (IN in) (NP (NN ligand) (NN binding) (NNS proteins))))) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))) (VP (VBD prompted) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (NN _PROT_)) (VP (VBZ shares) (NP (JJ common) (NN signal) (NN transduction) (NNS mechanisms)) (PP (IN with) (NP (NN _PROT_))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NP (NP (DT The) (NNS similarities)) (PP (IN in) (NP (NNS biofunctions)))) (CC and) (NP (NP (NNS differences)) (PP (IN in) (NP (NN ligand) (NN binding) (NNS proteins))))) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (VP (VBD prompted) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (NN _PROT2_)) (VP (VBZ shares) (NP (JJ common) (NN signal) (NN transduction) (NNS mechanisms)) (PP (IN with) (NP (NN _PROT_))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NP (NP (DT The) (NNS similarities)) (PP (IN in) (NP (NNS biofunctions)))) (CC and) (NP (NP (NNS differences)) (PP (IN in) (NP (NN ligand) (NN binding) (NNS proteins))))) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (VP (VBD prompted) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (NN _PROT_)) (VP (VBZ shares) (NP (JJ common) (NN signal) (NN transduction) (NNS mechanisms)) (PP (IN with) (NP (NN _PROT2_))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NP (NP (DT The) (NNS similarities)) (PP (IN in) (NP (NNS biofunctions)))) (CC and) (NP (NP (NNS differences)) (PP (IN in) (NP (NN ligand) (NN binding) (NNS proteins))))) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (VP (VBD prompted) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (NN _PROT2_)) (VP (VBZ shares) (NP (JJ common) (NN signal) (NN transduction) (NNS mechanisms)) (PP (IN with) (NP (NN _PROT_))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NP (NP (DT The) (NNS similarities)) (PP (IN in) (NP (NNS biofunctions)))) (CC and) (NP (NP (NNS differences)) (PP (IN in) (NP (NN ligand) (NN binding) (NNS proteins))))) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (VP (VBD prompted) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (NN _PROT_)) (VP (VBZ shares) (NP (JJ common) (NN signal) (NN transduction) (NNS mechanisms)) (PP (IN with) (NP (NN _PROT2_))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NP (NP (DT The) (NNS similarities)) (PP (IN in) (NP (NNS biofunctions)))) (CC and) (NP (NP (NNS differences)) (PP (IN in) (NP (NN ligand) (NN binding) (NNS proteins))))) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (VP (VBD prompted) (S (NP (PRP us)) (VP (TO to) (VP (VB investigate) (SBAR (IN whether) (S (NP (NN _PROT1_)) (VP (VBZ shares) (NP (JJ common) (NN signal) (NN transduction) (NNS mechanisms)) (PP (IN with) (NP (NN _PROT2_))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN examined) (NP (NP (JJ early) (NNS signals)) (VP (VBN triggered) (PP (IN by) (NP (NP (NN _PROT1_)) (CC or) (NP (NN _PROT2_)))) (PP (IN in) (NP (NP (DT a) (JJ multifactor-dependent) (JJ human) (JJ erythroleukemic) (NN cell) (NN line)) (, ,) (NP (NN TF-1))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (MD can) (ADVP (DT both)) (VP (VP (VB stimulate) (NP (NN cell) (NN proliferation))) (, ,) (VP (VB induce) (NP (NP (JJ similar) (NN pattern)) (PP (IN of) (NP (NN protein) (NN tyrosine) (NN phosphorylation))))) (, ,) (CC and) (VP (VB activate) (NP (NP (DT the) (JJ same) (NN proto-oncogene) (-LRB- -LRB-) (NN _PROT_) (-RRB- -RRB-) (NN expression)) (PP (IN in) (NP (NN TF-1) (NNS cells))))))))))) (. .)))
+1 #(S1 (S (S (NP (DT The) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (MD can) (ADVP (DT both)) (VP (VP (VB stimulate) (NP (NN cell) (NN proliferation))) (, ,) (VP (VB induce) (NP (NP (JJ similar) (NN pattern)) (PP (IN of) (NP (NN protein) (NN tyrosine) (NN phosphorylation))))) (, ,) (CC and) (VP (VB activate) (NP (NP (DT the) (JJ same) (NN proto-oncogene) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-) (NN expression)) (PP (IN in) (NP (NN TF-1) (NNS cells))))))))))) (. .)))
+1 #(S1 (S (S (NP (DT The) (NNS results)) (VP (VBD showed) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (MD can) (ADVP (DT both)) (VP (VP (VB stimulate) (NP (NN cell) (NN proliferation))) (, ,) (VP (VB induce) (NP (NP (JJ similar) (NN pattern)) (PP (IN of) (NP (NN protein) (NN tyrosine) (NN phosphorylation))))) (, ,) (CC and) (VP (VB activate) (NP (NP (DT the) (JJ same) (NN proto-oncogene) (-LRB- -LRB-) (NN _PROT2_) (-RRB- -RRB-) (NN expression)) (PP (IN in) (NP (NN TF-1) (NNS cells))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP imply) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP share) (NP (JJ similar) (JJ early) (NN signaling) (NNS events)) (PP (IN with) (NP (NP (DT the) (NN possibility)) (PP (IN of) (S (VP (VBG using) (NP (NP (DT the) (JJ same) (NN signal) (NN transducer)) (, ,) (NP (NN _PROT_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP imply) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VBP share) (NP (JJ similar) (JJ early) (NN signaling) (NNS events)) (PP (IN with) (NP (NP (DT the) (NN possibility)) (PP (IN of) (S (VP (VBG using) (NP (NP (DT the) (JJ same) (NN signal) (NN transducer)) (, ,) (NP (NN _PROT2_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT These) (NNS findings)) (VP (VBP imply) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VBP share) (NP (JJ similar) (JJ early) (NN signaling) (NNS events)) (PP (IN with) (NP (NP (DT the) (NN possibility)) (PP (IN of) (S (VP (VBG using) (NP (NP (DT the) (JJ same) (NN signal) (NN transducer)) (, ,) (NP (NN _PROT2_))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VBD tested) (SBAR (IN whether) (S (NP (ADJP (NN _PROT1_) (JJ induced)) (NN signaling)) (VP (MD can) (VP (VB be) (VP (VBN inhibited) (PP (IN by) (NP (NP (JJ _PROT2_) (NNS antibodies)) (SBAR (WHNP (WDT which)) (S (VP (VBD blocked) (NP (JJ _PROT_) (NNS functions)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VBD tested) (SBAR (IN whether) (S (NP (ADJP (NN _PROT1_) (JJ induced)) (NN signaling)) (VP (MD can) (VP (VB be) (VP (VBN inhibited) (PP (IN by) (NP (NP (JJ _PROT_) (NNS antibodies)) (SBAR (WHNP (WDT which)) (S (VP (VBD blocked) (NP (JJ _PROT2_) (NNS functions)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP We)) (ADVP (RB next)) (VP (VBD tested) (SBAR (IN whether) (S (NP (ADJP (NN _PROT_) (JJ induced)) (NN signaling)) (VP (MD can) (VP (VB be) (VP (VBN inhibited) (PP (IN by) (NP (NP (JJ _PROT1_) (NNS antibodies)) (SBAR (WHNP (WDT which)) (S (VP (VBD blocked) (NP (JJ _PROT2_) (NNS functions)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN observed) (SBAR (IN that) (S (NP (JJ _PROT1_) (NNS antibodies)) (VP (VBD abolished) (NP (NP (NP (NN cell) (NN proliferation)) (, ,) (NP (NN protein) (NN tyrosine) (NN phosphorylation)) (, ,) (CC and) (NP (NN _PROT2_) (NN gene) (NN expression))) (VP (VBN elicited) (PP (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT_)))) (PP (IN in) (NP (NN TF-1) (NNS cells))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN observed) (SBAR (IN that) (S (NP (JJ _PROT1_) (NNS antibodies)) (VP (VBD abolished) (NP (NP (NP (NN cell) (NN proliferation)) (, ,) (NP (NN protein) (NN tyrosine) (NN phosphorylation)) (, ,) (CC and) (NP (NN _PROT_) (NN gene) (NN expression))) (VP (VBN elicited) (PP (IN by) (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_)))) (PP (IN in) (NP (NN TF-1) (NNS cells))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN observed) (SBAR (IN that) (S (NP (JJ _PROT1_) (NNS antibodies)) (VP (VBD abolished) (NP (NP (NP (NN cell) (NN proliferation)) (, ,) (NP (NN protein) (NN tyrosine) (NN phosphorylation)) (, ,) (CC and) (NP (NN _PROT_) (NN gene) (NN expression))) (VP (VBN elicited) (PP (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_)))) (PP (IN in) (NP (NN TF-1) (NNS cells))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN observed) (SBAR (IN that) (S (NP (JJ _PROT_) (NNS antibodies)) (VP (VBD abolished) (NP (NP (NP (NN cell) (NN proliferation)) (, ,) (NP (NN protein) (NN tyrosine) (NN phosphorylation)) (, ,) (CC and) (NP (NN _PROT1_) (NN gene) (NN expression))) (VP (VBN elicited) (PP (IN by) (NP (NP (NN _PROT2_)) (CC or) (NP (NN _PROT_)))) (PP (IN in) (NP (NN TF-1) (NNS cells))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN observed) (SBAR (IN that) (S (NP (JJ _PROT_) (NNS antibodies)) (VP (VBD abolished) (NP (NP (NP (NN cell) (NN proliferation)) (, ,) (NP (NN protein) (NN tyrosine) (NN phosphorylation)) (, ,) (CC and) (NP (NN _PROT1_) (NN gene) (NN expression))) (VP (VBN elicited) (PP (IN by) (NP (NP (NN _PROT_)) (CC or) (NP (NN _PROT2_)))) (PP (IN in) (NP (NN TF-1) (NNS cells))))))))))) (. .)))
-1 #(S1 (S (S (NP (PRP It)) (VP (VBD was) (VP (VBN observed) (SBAR (IN that) (S (NP (JJ _PROT_) (NNS antibodies)) (VP (VBD abolished) (NP (NP (NP (NN cell) (NN proliferation)) (, ,) (NP (NN protein) (NN tyrosine) (NN phosphorylation)) (, ,) (CC and) (NP (NN _PROT_) (NN gene) (NN expression))) (VP (VBN elicited) (PP (IN by) (NP (NP (NN _PROT1_)) (CC or) (NP (NN _PROT2_)))) (PP (IN in) (NP (NN TF-1) (NNS cells))))))))))) (. .)))
-1 #(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NN _PROT1_) (NN antibody)) (VP (VBD inhibited) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NP (NN _PROT2_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT_)) (, ,))) (S (VP (TO to) (VP (VB transduce) (NP (NP (JJ early) (NNS signals)) (PP (IN in) (NP (NN TF-1) (NNS cells)))))))))) (. .)))
-1 #(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NN _PROT1_) (NN antibody)) (VP (VBD inhibited) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NP (NN _PROT_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT2_)) (, ,))) (S (VP (TO to) (VP (VB transduce) (NP (NP (JJ early) (NNS signals)) (PP (IN in) (NP (NN TF-1) (NNS cells)))))))))) (. .)))
-1 #(S1 (S (S (ADVP (RB Finally)) (, ,) (NP (NN _PROT_) (NN antibody)) (VP (VBD inhibited) (NP (NP (DT the) (NN ability)) (PP (IN of) (NP (NP (NN _PROT1_)) (, ,) (CONJP (CC but) (RB not)) (NP (NN _PROT2_)) (, ,))) (S (VP (TO to) (VP (VB transduce) (NP (NP (JJ early) (NNS signals)) (PP (IN in) (NP (NN TF-1) (NNS cells)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VP (VBP utilize) (NP (JJ different) (NN ligand) (NN binding) (NNS proteins))) (, ,) (CC but) (VP (VBP share) (NP (NP (NP (JJ common) (NN signal) (NN transducer)) (, ,) (NP (NN _PROT_)) (, ,)) (PP (IN in) (NP (NN TF-1) (NNS cells)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VP (VBP utilize) (NP (JJ different) (NN ligand) (NN binding) (NNS proteins))) (, ,) (CC but) (VP (VBP share) (NP (NP (NP (JJ common) (NN signal) (NN transducer)) (, ,) (NP (NN _PROT2_)) (, ,)) (PP (IN in) (NP (NN TF-1) (NNS cells)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP demonstrate) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VP (VBP utilize) (NP (JJ different) (NN ligand) (NN binding) (NNS proteins))) (, ,) (CC but) (VP (VBP share) (NP (NP (NP (JJ common) (NN signal) (NN transducer)) (, ,) (NP (NN _PROT2_)) (, ,)) (PP (IN in) (NP (NN TF-1) (NNS cells)))))))))) (. .)))
-1 #(S1 (S (NP (NP (NP (NN Cloning)) (CC and) (NP (NN characterization))) (PP (IN of) (NP (NP (NP (DT a) (JJ specific) (NN _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (CD _PROT1_)) (NN binding) (NN protein)) (ADJP (RB structurally) (JJ related) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN _PROT_) (NN alpha) (NN chain)))))) (. .))))
-1 #(S1 (S (NP (NP (NP (NN Cloning)) (CC and) (NP (NN characterization))) (PP (IN of) (NP (NP (NP (DT a) (JJ specific) (NN _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (CD _PROT1_)) (NN binding) (NN protein)) (ADJP (RB structurally) (JJ related) (PP (TO to) (NP (DT the) (NN _PROT2_) (NN _PROT2_) (NN alpha) (NN chain)))))) (. .))))
-1 #(S1 (S (NP (NP (NP (NN Cloning)) (CC and) (NP (NN characterization))) (PP (IN of) (NP (NP (NP (DT a) (JJ specific) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (CD _PROT_)) (NN binding) (NN protein)) (ADJP (RB structurally) (JJ related) (PP (TO to) (NP (DT the) (NN _PROT1_AND_PROT2_) (NN _PROT2_) (NN alpha) (NN chain)))))) (. .))))
-1 #(S1 (S (S (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN cytokine)) (VP (VBN secreted) (PP (IN by) (NP (VBN activated) (NN T) (NNS lymphocytes)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ shares) (NP (NP (ADJP (JJ many))) (, ,) (CONJP (CC but) (RB not)) (NP (DT all)) (, ,) (NP (JJ biological) (NNS activities))) (PP (IN with) (NP (NN _PROT_))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN cytokine)) (VP (VBN secreted) (PP (IN by) (NP (VBN activated) (NN T) (NNS lymphocytes)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ shares) (NP (NP (ADJP (JJ many))) (, ,) (CONJP (CC but) (RB not)) (NP (DT all)) (, ,) (NP (JJ biological) (NNS activities))) (PP (IN with) (NP (NN _PROT2_))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN cytokine)) (VP (VBN secreted) (PP (IN by) (NP (VBN activated) (NN T) (NNS lymphocytes)))) (SBAR (WHNP (WDT that)) (S (VP (VBZ shares) (NP (NP (ADJP (JJ many))) (, ,) (CONJP (CC but) (RB not)) (NP (DT all)) (, ,) (NP (JJ biological) (NNS activities))) (PP (IN with) (NP (NN _PROT2_))))))))) (. .)))
-1 #(S1 (S (S (S (NP (CD Two) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (NNS constituents)) (PP (IN of) (NP (NP (DT the) (NN _PROT1_) (NN receptor)) (, ,) (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 140-kDa)) (NN glycoprotein)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gammac)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))))) (, ,) (CC but) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ binds) (NP (NN _PROT_))))) (. .)))
-1 #(S1 (S (S (S (NP (CD Two) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (NNS constituents)) (PP (IN of) (NP (NP (DT the) (NN _PROT1_) (NN receptor)) (, ,) (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 140-kDa)) (NN glycoprotein)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gammac)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN _PROT_))))))))))))) (, ,) (CC but) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ binds) (NP (NN _PROT_))))) (. .)))
-1 #(S1 (S (S (S (NP (CD Two) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (NNS constituents)) (PP (IN of) (NP (NP (DT the) (NN _PROT1_) (NN receptor)) (, ,) (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 140-kDa)) (NN glycoprotein)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gammac)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))))))) (, ,) (CC but) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ binds) (NP (NN _PROT_))))) (. .)))
-1 #(S1 (S (S (S (NP (CD Two) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (NNS constituents)) (PP (IN of) (NP (NP (DT the) (NN _PROT1_) (NN receptor)) (, ,) (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 140-kDa)) (NN glycoprotein)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gammac)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))))) (, ,) (CC but) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ binds) (NP (NN _PROT2_))))) (. .)))
-1 #(S1 (S (S (S (NP (CD Two) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (NNS constituents)) (PP (IN of) (NP (NP (DT the) (NN _PROT_) (NN receptor)) (, ,) (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 140-kDa)) (NN glycoprotein)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gammac)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN _PROT_))))))))))))) (, ,) (CC but) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ binds) (NP (NN _PROT_))))) (. .)))
-1 #(S1 (S (S (S (NP (CD Two) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (NNS constituents)) (PP (IN of) (NP (NP (DT the) (NN _PROT_) (NN receptor)) (, ,) (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 140-kDa)) (NN glycoprotein)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gammac)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT2_) (NN _PROT2_))))))))))))) (, ,) (CC but) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ binds) (NP (NN _PROT_))))) (. .)))
-1 #(S1 (S (S (S (NP (CD Two) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (NNS constituents)) (PP (IN of) (NP (NP (DT the) (NN _PROT_) (NN receptor)) (, ,) (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 140-kDa)) (NN glycoprotein)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gammac)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT_) (NN _PROT_))))))))))))) (, ,) (CC but) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ binds) (NP (NN _PROT2_))))) (. .)))
-1 #(S1 (S (S (S (NP (CD Two) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (NNS constituents)) (PP (IN of) (NP (NP (DT the) (NN _PROT_) (NN receptor)) (, ,) (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 140-kDa)) (NN glycoprotein)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gammac)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT1_AND_PROT2_) (NN _PROT2_))))))))))))) (, ,) (CC but) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ binds) (NP (NN _PROT_))))) (. .)))
-1 #(S1 (S (S (S (NP (CD Two) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (NNS constituents)) (PP (IN of) (NP (NP (DT the) (NN _PROT_) (NN receptor)) (, ,) (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 140-kDa)) (NN glycoprotein)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gammac)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN _PROT_))))))))))))) (, ,) (CC but) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ binds) (NP (NN _PROT2_))))) (. .)))
-1 #(S1 (S (S (S (NP (CD Two) (NNS proteins)) (VP (VBP have) (VP (VBN been) (VP (VBN described) (PP (IN as) (NP (NP (NNS constituents)) (PP (IN of) (NP (NP (DT the) (NN _PROT_) (NN receptor)) (, ,) (NP (NP (NP (DT a) (ADJP (RB approximately) (JJ 140-kDa)) (NN glycoprotein)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (CC and) (NP (NP (NP (DT the) (NN gamma) (NN chain)) (PRN (-LRB- -LRB-) (NP (NN gammac)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN _PROT1_))))))))))))) (, ,) (CC but) (S (NP (NP (DT neither)) (PP (IN of) (NP (DT these) (NNS proteins)))) (VP (VBZ binds) (NP (NN _PROT2_))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN cloned) (NP (NP (DT a) (NN cDNA)) (VP (VBG encoding) (NP (NP (NP (DT an) (NN _PROT1_) (NN binding) (NN protein)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (PP (IN from) (NP (DT the) (NN Caki-1) (JJ human) (JJ renal) (NN carcinoma) (NN cell) (NN line))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (NN _PROT1_)) (VP (VBZ shows) (NP (NP (NN homology)) (PP (IN with) (NP (DT the) (NN _PROT2_) (NN receptor)))) (, ,) (CC and) (PP (TO to) (NP (DT a) (JJR lesser) (NN extent))) (, ,) (PP (IN with) (NP (DT the) (NN prolactin) (NN receptor))))) (. .)))
+1 #(S1 (S (S (NP (NP (NN COS-7) (NNS cells)) (VP (VBN transfected) (PP (IN with) (NP (DT the) (NN _PROT1_) (NN cDNA))))) (VP (VP (VBP bind) (NP (NN _PROT2_)) (PP (IN with) (NP (JJ high) (NN affinity)))) (CC but) (VP (VBP do) (RB not) (VP (VB bind) (NP (NN _PROT_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN COS-7) (NNS cells)) (VP (VBN transfected) (PP (IN with) (NP (DT the) (NN _PROT1_) (NN cDNA))))) (VP (VP (VBP bind) (NP (NN _PROT_)) (PP (IN with) (NP (JJ high) (NN affinity)))) (CC but) (VP (VBP do) (RB not) (VP (VB bind) (NP (NN _PROT2_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN COS-7) (NNS cells)) (VP (VBN transfected) (PP (IN with) (NP (DT the) (NN _PROT_) (NN cDNA))))) (VP (VP (VBP bind) (NP (NN _PROT1_)) (PP (IN with) (NP (JJ high) (NN affinity)))) (CC but) (VP (VBP do) (RB not) (VP (VB bind) (NP (NN _PROT2_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN COS-7) (NNS cells)) (VP (VBN co-transfected) (PP (IN with) (NP (DT the) (VBN cloned) (NP (NP (NN _PROT1_) (NN cDNA)) (CC and) (NP (NN _PROT2_) (NN cDNA))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN reconstitution)) (PP (IN of) (NP (NP (DT a) (JJ small) (NN number)) (PP (IN of) (NP (NP (NNS receptors)) (SBAR (WHNP (WDT that)) (S (VP (VBD recognized) (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN COS-7) (NNS cells)) (VP (VBN co-transfected) (PP (IN with) (NP (DT the) (VBN cloned) (NP (NP (NN _PROT1_) (NN cDNA)) (CC and) (NP (NN _PROT_) (NN cDNA))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN reconstitution)) (PP (IN of) (NP (NP (DT a) (JJ small) (NN number)) (PP (IN of) (NP (NP (NNS receptors)) (SBAR (WHNP (WDT that)) (S (VP (VBD recognized) (NP (CC both) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN COS-7) (NNS cells)) (VP (VBN co-transfected) (PP (IN with) (NP (DT the) (VBN cloned) (NP (NP (NN _PROT1_) (NN cDNA)) (CC and) (NP (NN _PROT_) (NN cDNA))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN reconstitution)) (PP (IN of) (NP (NP (DT a) (JJ small) (NN number)) (PP (IN of) (NP (NP (NNS receptors)) (SBAR (WHNP (WDT that)) (S (VP (VBD recognized) (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN COS-7) (NNS cells)) (VP (VBN co-transfected) (PP (IN with) (NP (DT the) (VBN cloned) (NP (NP (NN _PROT_) (NN cDNA)) (CC and) (NP (NN _PROT1_) (NN cDNA))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN reconstitution)) (PP (IN of) (NP (NP (DT a) (JJ small) (NN number)) (PP (IN of) (NP (NP (NNS receptors)) (SBAR (WHNP (WDT that)) (S (VP (VBD recognized) (NP (CC both) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN COS-7) (NNS cells)) (VP (VBN co-transfected) (PP (IN with) (NP (DT the) (VBN cloned) (NP (NP (NN _PROT_) (NN cDNA)) (CC and) (NP (NN _PROT1_) (NN cDNA))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN reconstitution)) (PP (IN of) (NP (NP (DT a) (JJ small) (NN number)) (PP (IN of) (NP (NP (NNS receptors)) (SBAR (WHNP (WDT that)) (S (VP (VBD recognized) (NP (CC both) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN COS-7) (NNS cells)) (VP (VBN co-transfected) (PP (IN with) (NP (DT the) (VBN cloned) (NP (NP (NN _PROT_) (NN cDNA)) (CC and) (NP (NN _PROT_) (NN cDNA))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN reconstitution)) (PP (IN of) (NP (NP (DT a) (JJ small) (NN number)) (PP (IN of) (NP (NP (NNS receptors)) (SBAR (WHNP (WDT that)) (S (VP (VBD recognized) (NP (CC both) (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_)))))))))))))) (. .)))
+1 #(S1 (S (NP (NP (JJ _PROT1_) (NN interaction)) (PP (IN of) (NP (JJ primary) (NN HIV-1) (NN _PROT2_) (NNS glycoproteins))) (PP (IN with) (NP (DT the) (NN chemokine) (NN receptor) (NN _PROT_))) (. .))))
-1 #(S1 (S (NP (NP (JJ _PROT1_) (NN interaction)) (PP (IN of) (NP (JJ primary) (NN HIV-1) (NN _PROT_) (NNS glycoproteins))) (PP (IN with) (NP (DT the) (NN chemokine) (NN receptor) (NN _PROT2_))) (. .))))
-1 #(S1 (S (NP (NP (JJ _PROT_) (NN interaction)) (PP (IN of) (NP (JJ primary) (NN HIV-1) (NN _PROT1_) (NNS glycoproteins))) (PP (IN with) (NP (DT the) (NN chemokine) (NN receptor) (NN _PROT2_))) (. .))))
-1 #(S1 (S (S (PP (IN For) (NP (NP (JJ efficient) (NN entry)) (PP (IN into) (NP (NN target) (NNS cells))))) (, ,) (NP (NP (JJ primary) (ADJP (ADJP (JJ macrophage-tropic)) (CC and) (ADJP (JJ laboratory-adapted))) (JJ human) (NN immunodeficiency) (NNS viruses)) (NP (NP (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-)))) (VP (VBP require) (NP (NP (NP (JJ particular) (NN chemokine) (NNS receptors)) (, ,) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_)))) (, ,) (ADVP (RB respectively)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (JJ primary) (NN receptor) (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (NP (CD 1-6))) (-RRB- -RRB-)))))) (. .)))
-1 #(S1 (S (S (PP (IN For) (NP (NP (JJ efficient) (NN entry)) (PP (IN into) (NP (NN target) (NNS cells))))) (, ,) (NP (NP (JJ primary) (ADJP (ADJP (JJ macrophage-tropic)) (CC and) (ADJP (JJ laboratory-adapted))) (JJ human) (NN immunodeficiency) (NNS viruses)) (NP (NP (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-)))) (VP (VBP require) (NP (NP (NP (JJ particular) (NN chemokine) (NNS receptors)) (, ,) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_)))) (, ,) (ADVP (RB respectively)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (JJ primary) (NN receptor) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (NP (CD 1-6))) (-RRB- -RRB-)))))) (. .)))
-1 #(S1 (S (S (PP (IN For) (NP (NP (JJ efficient) (NN entry)) (PP (IN into) (NP (NN target) (NNS cells))))) (, ,) (NP (NP (JJ primary) (ADJP (ADJP (JJ macrophage-tropic)) (CC and) (ADJP (JJ laboratory-adapted))) (JJ human) (NN immunodeficiency) (NNS viruses)) (NP (NP (NN type) (CD 1)) (PRN (-LRB- -LRB-) (NP (NN HIV-1)) (-RRB- -RRB-)))) (VP (VBP require) (NP (NP (NP (JJ particular) (NN chemokine) (NNS receptors)) (, ,) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_)))) (, ,) (ADVP (RB respectively)) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (DT the) (JJ primary) (NN receptor) (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (NP (CD 1-6))) (-RRB- -RRB-)))))) (. .)))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT1_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT2_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT_) (NNS ligands)) (, ,) (NP (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT1_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT2_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT_) (NNS ligands)) (, ,) (NP (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT1_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT2_) (NNS ligands)) (, ,) (NP (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT1_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT_) (NNS ligands)) (, ,) (NP (NP (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (-LRB- _PROT2_) (NN _PROT2_) (-RRB- _PROT2_) (NN _PROT2_)) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT1_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT_) (NNS ligands)) (, ,) (NP (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT1_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT2_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT_) (NNS ligands)) (, ,) (NP (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT1_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT2_) (NNS ligands)) (, ,) (NP (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT1_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT_) (NNS ligands)) (, ,) (NP (NP (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (-LRB- _PROT2_) (NN _PROT2_) (-RRB- _PROT2_) (NN _PROT2_)) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT1_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT_) (NNS ligands)) (, ,) (NP (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT1_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT2_) (NNS ligands)) (, ,) (NP (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT1_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT_) (NNS ligands)) (, ,) (NP (NP (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (-LRB- _PROT2_) (NN _PROT2_) (-RRB- _PROT2_) (NN _PROT2_)) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT1_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT_) (NNS ligands)) (, ,) (NP (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT1_) (NNS ligands)) (, ,) (NP (NP (NN _PROT2_) (JJ _PROT2_) (NN _PROT2_) (-LRB- _PROT2_) (NN _PROT2_) (-RRB- _PROT2_) (NN _PROT2_)) (CC and) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT1_) (NNS ligands)) (, ,) (NP (NP (NN _PROT_) (JJ _PROT_) (NN _PROT_) (-LRB- _PROT_) (NN _PROT_) (-RRB- _PROT_) (NN _PROT_)) (CC and) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT a) (NN complex)) (PP (IN of) (NP (NP (NP (NN _PROT_)) (, ,) (NP (DT the) (JJ exterior) (NN envelope) (NN glycoprotein)) (, ,) (PP (IN of) (NP (JJ macrophage-tropic) (JJ primary) (NN HIV-1)))) (CC and) (NP (JJ soluble) (NN _PROT_))))) (VP (VP (VBZ interacts) (ADVP (RB specifically)) (PP (IN with) (NP (NN _PROT_)))) (CC and) (VP (VBZ inhibits) (NP (NP (DT the) (NN binding)) (PP (IN of) (NP (NP (DT the) (JJ natural) (NN _PROT_) (NNS ligands)) (, ,) (NP (NP (NN _PROT1_) (JJ _PROT1_) (NN _PROT1_) (-LRB- _PROT1_) (NN _PROT1_) (-RRB- _PROT1_) (NN _PROT1_)) (CC and) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NNS refs) (QP (CD 7) (, ,) (CD 8))) (-RRB- -RRB-)))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (JJ apparent) (NN affinity)) (PP (IN of) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))))) (VP (VBD was) (ADJP (RB dramatically) (JJR lower)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ soluble) (NN _PROT_))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ apparent) (NN affinity)) (PP (IN of) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))))) (VP (VBD was) (ADJP (RB dramatically) (JJR lower)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ soluble) (NN _PROT2_))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ apparent) (NN affinity)) (PP (IN of) (NP (NP (DT the) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))))) (VP (VBD was) (ADJP (RB dramatically) (JJR lower)) (PP (IN in) (NP (NP (DT the) (NN absence)) (PP (IN of) (NP (JJ soluble) (NN _PROT2_))))))) (. .)))
-1 #(S1 (S (S (ADVP (RB Additionally)) (, ,) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN _PROT1_))) (, ,) (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (DT a) (JJ two-domain) (NN _PROT2_) (NN fragment)) (CC and) (NP (NN _PROT_))))) (VP (VBD was) (VP (VBN observed)))) (. .)))
-1 #(S1 (S (S (ADVP (RB Additionally)) (, ,) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN _PROT1_))) (, ,) (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (DT a) (JJ two-domain) (NN _PROT_) (NN fragment)) (CC and) (NP (NN _PROT2_))))) (VP (VBD was) (VP (VBN observed)))) (. .)))
+1 #(S1 (S (S (ADVP (RB Additionally)) (, ,) (PP (IN in) (DT the) (NN absence) (IN of) (NP (NN _PROT_))) (, ,) (NP (NP (DT an) (NN interaction)) (PP (IN between) (NP (NP (DT a) (JJ two-domain) (NN _PROT1_) (NN fragment)) (CC and) (NP (NN _PROT2_))))) (VP (VBD was) (VP (VBN observed)))) (. .)))
+1 #(S1 (S (S (NP (NP (DT A) (NN _PROT1_) (NN fragment)) (VP (VBG retaining) (NP (NP (DT the) (JJ _PROT2_) (NN site)) (CC and) (NP (JJ overlapping) (NNS epitopes))))) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT_))) (SBAR (RB only) (IN if) (S (NP (NP (DT the) (JJ V3) (NN loop)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB specify) (NP (NP (NN HIV-1) (NN tropism)) (CC and) (NP (NN chemokine) (NN receptor) (NN choice))))))) (, ,)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ present) (PP (IN on) (NP (DT the) (NN molecule))))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT A) (NN _PROT1_) (NN fragment)) (VP (VBG retaining) (NP (NP (DT the) (JJ _PROT_) (NN site)) (CC and) (NP (JJ overlapping) (NNS epitopes))))) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT2_))) (SBAR (RB only) (IN if) (S (NP (NP (DT the) (JJ V3) (NN loop)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB specify) (NP (NP (NN HIV-1) (NN tropism)) (CC and) (NP (NN chemokine) (NN receptor) (NN choice))))))) (, ,)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ present) (PP (IN on) (NP (DT the) (NN molecule))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT A) (NN _PROT_) (NN fragment)) (VP (VBG retaining) (NP (NP (DT the) (JJ _PROT1_) (NN site)) (CC and) (NP (JJ overlapping) (NNS epitopes))))) (VP (VBD was) (ADJP (JJ able) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NN _PROT2_))) (SBAR (RB only) (IN if) (S (NP (NP (DT the) (JJ V3) (NN loop)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD can) (VP (VB specify) (NP (NP (NN HIV-1) (NN tropism)) (CC and) (NP (NN chemokine) (NN receptor) (NN choice))))))) (, ,)) (VP (VBD was) (ADVP (RB also)) (ADJP (JJ present) (PP (IN on) (NP (DT the) (NN molecule))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN Neutralizing) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (UCP (CC either) (ADJP (JJ _PROT1_)) (CC or) (NP (NN V3))) (NNS epitopes)) (PP (IN on) (NP (NN _PROT2_))))))) (VP (VBD blocked) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (JJ _PROT_) (NNS complexes))) (PP (IN with) (NP (NN _PROT_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN Neutralizing) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (UCP (CC either) (ADJP (JJ _PROT1_)) (CC or) (NP (NN V3))) (NNS epitopes)) (PP (IN on) (NP (NN _PROT_))))))) (VP (VBD blocked) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (JJ _PROT2_) (NNS complexes))) (PP (IN with) (NP (NN _PROT_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN Neutralizing) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (UCP (CC either) (ADJP (JJ _PROT1_)) (CC or) (NP (NN V3))) (NNS epitopes)) (PP (IN on) (NP (NN _PROT_))))))) (VP (VBD blocked) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (JJ _PROT2_) (NNS complexes))) (PP (IN with) (NP (NN _PROT_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN Neutralizing) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (UCP (CC either) (ADJP (JJ _PROT1_)) (CC or) (NP (NN V3))) (NNS epitopes)) (PP (IN on) (NP (NN _PROT_))))))) (VP (VBD blocked) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (JJ _PROT_) (NNS complexes))) (PP (IN with) (NP (NN _PROT2_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN Neutralizing) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (UCP (CC either) (ADJP (JJ _PROT_)) (CC or) (NP (NN V3))) (NNS epitopes)) (PP (IN on) (NP (NN _PROT1_))))))) (VP (VBD blocked) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (JJ _PROT2_) (NNS complexes))) (PP (IN with) (NP (NN _PROT_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN Neutralizing) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (UCP (CC either) (ADJP (JJ _PROT_)) (CC or) (NP (NN V3))) (NNS epitopes)) (PP (IN on) (NP (NN _PROT1_))))))) (VP (VBD blocked) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (JJ _PROT2_) (NNS complexes))) (PP (IN with) (NP (NN _PROT_)))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN Neutralizing) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (UCP (CC either) (ADJP (JJ _PROT_)) (CC or) (NP (NN V3))) (NNS epitopes)) (PP (IN on) (NP (NN _PROT1_))))))) (VP (VBD blocked) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (JJ _PROT_) (NNS complexes))) (PP (IN with) (NP (NN _PROT2_)))))) (. .)))
+1 #(S1 (S (S (NP (NP (NN Neutralizing) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (UCP (CC either) (ADJP (JJ _PROT_)) (CC or) (NP (NN V3))) (NNS epitopes)) (PP (IN on) (NP (NN _PROT_))))))) (VP (VBD blocked) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (JJ _PROT1_AND_PROT2_) (NNS complexes))) (PP (IN with) (NP (NN _PROT_)))))) (. .)))
+1 #(S1 (S (S (NP (NP (NN Neutralizing) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (UCP (CC either) (ADJP (JJ _PROT_)) (CC or) (NP (NN V3))) (NNS epitopes)) (PP (IN on) (NP (NN _PROT_))))))) (VP (VBD blocked) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (JJ _PROT1_) (NNS complexes))) (PP (IN with) (NP (NN _PROT2_)))))) (. .)))
+1 #(S1 (S (S (NP (NP (NN Neutralizing) (NNS antibodies)) (VP (VBN directed) (PP (IN against) (NP (NP (UCP (CC either) (ADJP (JJ _PROT_)) (CC or) (NP (NN V3))) (NNS epitopes)) (PP (IN on) (NP (NN _PROT_))))))) (VP (VBD blocked) (NP (NP (DT the) (NN interaction)) (PP (IN of) (NP (JJ _PROT1_) (NNS complexes))) (PP (IN with) (NP (NN _PROT2_)))))) (. .)))
-1 #(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NP (NN HIV-1) (NN attachment)) (PP (TO to) (NP (NN _PROT1_)))) (VP (VBZ creates) (NP (NP (DT a) (JJ high-affinity) (NN binding) (NN site)) (PP (IN for) (NP (NN _PROT2_)))) (, ,) (S (VP (VBG leading) (PP (TO to) (NP (NP (NN membrane) (NN fusion)) (CC and) (NP (NN virus) (NN entry))))))))))) (. .)))
+1 #(S1 (S (NP (NP (NP (NN Interaction)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN with) (NP (NN _PROT2_) (NN _PROT2_)))) (: :) (NP (NP (NP (NN binding)) (CC and) (NP (NN inhibition))) (PP (IN of) (NP (NN amyloid) (NN formation)))) (. .))))
-1 #(S1 (S (S (NP (NP (JJ Aggregated) (NN _PROT1_) (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_) (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (JJ key) (NN component)) (PP (IN of) (NP (NP (DT the) (JJ amyloid) (NNS depositions)) (VP (VBN found) (PP (IN in) (NP (NP (DT the) (NNS brains)) (PP (IN of) (NP (NP (NNS patients)) (PP (IN with) (NP (NN Alzheimer) (POS 's) (NN disease))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN analysis)) (PP (IN of) (NP (NP (NNS complexes)) (PP (IN of) (NP (NN _PROT1_) (NN _PROT1_))) (PP (IN with) (NP (NP (NN CSF) (NNS proteins)) (PP (IN in) (NP (DT a) (NN KBr) (NN gradient)))))))) (VP (VBD revealed) (NP (NP (DT an) (NN association)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_))) (PP (PP (RB only) (IN with) (NP (JJ free) (NNS proteins))) (CC and) (PP (RB not) (IN with) (NP (NN lipoprotein) (NNS particles))))))) (. .)))
-1 #(S1 (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ second) (JJ major) (NN CSF) (NN protein)) (, ,)) (VP (VP (VBD formed) (NP (NP (JJ SDS-stable) (NNS complexes)) (PP (IN with) (NP (NN _PROT_) (NN _PROT_))))) (CC and) (VP (ADVP (RB significantly)) (VBD decreased) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (DT _PROT_) (NN _PROT_) (NN fibril) (NN formation)))))) (. .)))
+1 #(S1 (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ second) (JJ major) (NN CSF) (NN protein)) (, ,)) (VP (VP (VBD formed) (NP (NP (JJ SDS-stable) (NNS complexes)) (PP (IN with) (NP (NN _PROT2_) (NN _PROT2_))))) (CC and) (VP (ADVP (RB significantly)) (VBD decreased) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (DT _PROT_) (NN _PROT_) (NN fibril) (NN formation)))))) (. .)))
-1 #(S1 (S (NP (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ second) (JJ major) (NN CSF) (NN protein)) (, ,)) (VP (VP (VBD formed) (NP (NP (JJ SDS-stable) (NNS complexes)) (PP (IN with) (NP (NN _PROT_) (NN _PROT_))))) (CC and) (VP (ADVP (RB significantly)) (VBD decreased) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (DT _PROT2_) (NN _PROT2_) (NN fibril) (NN formation)))))) (. .)))
+1 #(S1 (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ second) (JJ major) (NN CSF) (NN protein)) (, ,)) (VP (VP (VBD formed) (NP (NP (JJ SDS-stable) (NNS complexes)) (PP (IN with) (NP (NN _PROT2_) (NN _PROT2_))))) (CC and) (VP (ADVP (RB significantly)) (VBD decreased) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (DT _PROT_) (NN _PROT_) (NN fibril) (NN formation)))))) (. .)))
-1 #(S1 (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT1_)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ second) (JJ major) (NN CSF) (NN protein)) (, ,)) (VP (VP (VBD formed) (NP (NP (JJ SDS-stable) (NNS complexes)) (PP (IN with) (NP (NN _PROT_) (NN _PROT_))))) (CC and) (VP (ADVP (RB significantly)) (VBD decreased) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (DT _PROT2_) (NN _PROT2_) (NN fibril) (NN formation)))))) (. .)))
-1 #(S1 (S (NP (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN _PROT_)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ second) (JJ major) (NN CSF) (NN protein)) (, ,)) (VP (VP (VBD formed) (NP (NP (JJ SDS-stable) (NNS complexes)) (PP (IN with) (NP (NN _PROT1_) (NN _PROT1_))))) (CC and) (VP (ADVP (RB significantly)) (VBD decreased) (NP (NP (DT the) (NN rate)) (PP (IN of) (NP (DT _PROT2_) (NN _PROT2_) (NN fibril) (NN formation)))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NP (JJ physiological) (NNS buffers)) (CC and) (NP (NN CSF)))) (, ,) (NP (NN _PROT1_)) (ADVP (RB exclusively)) (VP (VBD decreased) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN _PROT2_) (NN _PROT2_) (NNS pentamers)))))) (. .)))
+1 #(S1 (S (S (NP (JJ Endogenous) (NN _PROT1_AND_PROT2_) (NN _PROT2_) (NNS complexes)) (VP (VBD were) (VP (VBN detected) (PP (IN in) (NP (JJ human) (NN CSF))) (PP (IN by) (NP (NN immunoprecipitation)))))) (. .)))
+1 #(S1 (S (S (S (VP (VBG Using) (NP (NP (JJ site-directed) (NN mutagenesis)) (CC and) (NP (JJ computer-assisted) (NN modelling))))) (, ,) (NP (PRP we)) (VP (VBD identified) (NP (NP (NN amino) (NN acid) (NNS residues)) (PP (IN on) (NP (NP (DT the) (NN surface)) (PP (IN of) (NP (DT the) (NN _PROT1_) (NN monomer))))) (SBAR (WHNP (WDT that)) (S (VP (VBP interact) (PP (IN with) (NP (NN _PROT2_) (NN _PROT2_))))))))) (. .)))
-1 #(S1 (S (NP (PRP We)) (VP (VBP propose) (SBAR (IN that) (S (NP (DT _PROT1_) (NN _PROT1_) (NN binding) (NNS proteins)) (VP (VP (VBP play) (NP (DT a) (JJ key) (NN role)) (PP (IN in) (NP (NP (DT the) (NN modulation)) (PP (IN of) (NP (DT _PROT2_) (NN _PROT2_) (NN aggregation)))))) (CC and) (ADVP (RB normally)) (VP (VBP prevent) (NP (NN amyloid) (NN formation)) (PP (PP (IN in) (NP (JJ biological) (NNS fluids))) (CC and) (PP (IN in) (NP (DT the) (NN brain))))))))) (. .)))
+1 #(S1 (S (S (NP (NN Proto-oncoprotein) (NN _PROT1_)) (VP (VBZ interacts) (PP (IN with) (NP (NN _PROT2_))) (PP (IN in) (NP (NP (VBN activated) (NNS thymocytes)) (CC and) (NP (JJ peripheral) (NN T) (NNS cells)))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT1_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT2_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT1_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT2_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
+1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT1_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
+1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT1_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
+1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT1_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT1_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT2_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT1_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT1_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT1_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT1_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT1_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT1_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (, ,) (CC and) (NP (NN _PROT_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (, ,) (CC and) (NP (NN _PROT2_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ molecular) (NN adapter) (NN _PROT_)) (VP (VP (VBZ is) (ADVP (RB rapidly)) (ADJP (NN tyrosine) (JJ phosphorylated)) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))) (CC and) (VP (VBZ associates) (PP (IN with) (NP (NP (NN _PROT_) (NN homology) (NN domain-2) (-LRB- -LRB-) (NN SH2) (-RRB- -RRB-) (NN /SH3) (JJ domain-containing) (NNS adapters)) (PP (JJ such) (IN as) (NP (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (, ,) (CC and) (NP (NN _PROT2_))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VBP interact) (PP (IN with) (NP (NP (NN guanine) (NN nucleotide) (NN exchange) (NNS factors)) (ADJP (JJ specific) (PP (IN for) (NP (DT the) (NN Ras) (NN family)))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT This)) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (MD may) (VP (VB link) (NP (NN _PROT2_) (NN activation)) (PP (TO to) (NP (NP (NNS molecules)) (SBAR (WHNP (WDT that)) (S (VP (VBP regulate) (NP (NN GTP) (NN binding) (NNS proteins))))))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ SH2/SH3-containing) (NN protein) (NN _PROT1_)) (ADVP (RB also)) (VP (VBZ contains) (NP (NP (DT a) (JJ guanine) (NN nucleotide) (NN exchange) (NN factor)) (NN domain)))) (, ,) (CC and) (S (NP (NN _PROT2_)) (VP (VBZ has) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (NP (NP (NN thymocyte) (NN development)) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (JJ peripheral) (NN T) (NNS cells))) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT_)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ SH2/SH3-containing) (NN protein) (NN _PROT1_)) (ADVP (RB also)) (VP (VBZ contains) (NP (NP (DT a) (JJ guanine) (NN nucleotide) (NN exchange) (NN factor)) (NN domain)))) (, ,) (CC and) (S (NP (NN _PROT_)) (VP (VBZ has) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (NP (NP (NN thymocyte) (NN development)) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (JJ peripheral) (NN T) (NNS cells))) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT2_)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (JJ SH2/SH3-containing) (NN protein) (NN _PROT_)) (ADVP (RB also)) (VP (VBZ contains) (NP (NP (DT a) (JJ guanine) (NN nucleotide) (NN exchange) (NN factor)) (NN domain)))) (, ,) (CC and) (S (NP (NN _PROT1_)) (VP (VBZ has) (NP (DT a) (JJ crucial) (NN role)) (PP (IN in) (NP (NP (NN thymocyte) (NN development)) (CC and) (NP (NP (NN activation)) (PP (IN of) (NP (JJ peripheral) (NN T) (NNS cells))) (PP (VBG following) (NP (NP (NN stimulation)) (PP (IN through) (NP (DT the) (NN _PROT2_)))))))))) (. .)))
+1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))) (VP (VBP form) (NP (NP (JJ inducible) (JJ molecular) (NNS complexes)) (PP (IN in) (NP (NP (JJ _PROT_) (NN murine) (NNS thymocytes)) (CC and) (NP (JJ peripheral) (NN T) (NNS cells)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ pervanadate-treated) (NN T) (NNS cells))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))) (VP (VBP form) (NP (NP (JJ inducible) (JJ molecular) (NNS complexes)) (PP (IN in) (NP (NP (JJ _PROT2_) (NN murine) (NNS thymocytes)) (CC and) (NP (JJ peripheral) (NN T) (NNS cells)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ pervanadate-treated) (NN T) (NNS cells))))))))) (. .)))
-1 #(S1 (S (ADVP (RB Here)) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))) (VP (VBP form) (NP (NP (JJ inducible) (JJ molecular) (NNS complexes)) (PP (IN in) (NP (NP (JJ _PROT2_) (NN murine) (NNS thymocytes)) (CC and) (NP (JJ peripheral) (NN T) (NNS cells)) (CONJP (RB as) (RB well) (IN as)) (NP (JJ pervanadate-treated) (NN T) (NNS cells))))))))) (. .)))
+1 #(S1 (S (S (NP (NN _PROT1_AND_PROT2_) (NNS interactions)) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ detectable) (PP (IN in) (NP (NP (ADJP (RB freshly) (VBN isolated)) (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ gene-targeted) (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBP lack) (NP (NP (DT the) (ADJP (NN T) (JJ cell-specific)) (JJ inhibitory) (NN receptor) (NN _PROT_)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN _PROT_)) (VP (VBZ is) (VP (VBN hyperphosphorylated) (PP (IN on) (NP (NN tyrosine) (NNS residues)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT1_) (NNS interactions)) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ detectable) (PP (IN in) (NP (NP (ADJP (RB freshly) (VBN isolated)) (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ gene-targeted) (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBP lack) (NP (NP (DT the) (ADJP (NN T) (JJ cell-specific)) (JJ inhibitory) (NN receptor) (NN _PROT2_)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN _PROT_)) (VP (VBZ is) (VP (VBN hyperphosphorylated) (PP (IN on) (NP (NN tyrosine) (NNS residues)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT1_) (NNS interactions)) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ detectable) (PP (IN in) (NP (NP (ADJP (RB freshly) (VBN isolated)) (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ gene-targeted) (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBP lack) (NP (NP (DT the) (ADJP (NN T) (JJ cell-specific)) (JJ inhibitory) (NN receptor) (NN _PROT_)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN _PROT2_)) (VP (VBZ is) (VP (VBN hyperphosphorylated) (PP (IN on) (NP (NN tyrosine) (NNS residues)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT1_) (NNS interactions)) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ detectable) (PP (IN in) (NP (NP (ADJP (RB freshly) (VBN isolated)) (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ gene-targeted) (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBP lack) (NP (NP (DT the) (ADJP (NN T) (JJ cell-specific)) (JJ inhibitory) (NN receptor) (NN _PROT2_)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN _PROT_)) (VP (VBZ is) (VP (VBN hyperphosphorylated) (PP (IN on) (NP (NN tyrosine) (NNS residues)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT1_) (NNS interactions)) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ detectable) (PP (IN in) (NP (NP (ADJP (RB freshly) (VBN isolated)) (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ gene-targeted) (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBP lack) (NP (NP (DT the) (ADJP (NN T) (JJ cell-specific)) (JJ inhibitory) (NN receptor) (NN _PROT_)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN _PROT2_)) (VP (VBZ is) (VP (VBN hyperphosphorylated) (PP (IN on) (NP (NN tyrosine) (NNS residues)))))))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NN _PROT_) (NNS interactions)) (VP (VBP are) (ADVP (RB also)) (ADJP (JJ detectable) (PP (IN in) (NP (NP (ADJP (RB freshly) (VBN isolated)) (NN T) (NNS cells)) (PP (IN from) (NP (NP (JJ gene-targeted) (NNS mice)) (SBAR (WHNP (WDT that)) (S (VP (VBP lack) (NP (NP (DT the) (ADJP (NN T) (JJ cell-specific)) (JJ inhibitory) (NN receptor) (NN _PROT1_)) (, ,) (SBAR (WHPP (IN in) (WHNP (WDT which))) (S (NP (NN _PROT2_)) (VP (VBZ is) (VP (VBN hyperphosphorylated) (PP (IN on) (NP (NN tyrosine) (NNS residues)))))))))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_))))) (VP (VP (VBZ is) (ADVP (RB directly)) (VP (VBN mediated) (PP (IN via) (NP (NP (DT the) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT_))))))) (CC and) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (VP (VP (VBZ is) (ADVP (RB directly)) (VP (VBN mediated) (PP (IN via) (NP (NP (DT the) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT2_))))))) (CC and) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT1_)) (CC and) (NP (NN _PROT_))))) (VP (VP (VBZ is) (ADVP (RB directly)) (VP (VBN mediated) (PP (IN via) (NP (NP (DT the) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT_))))))) (CC and) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (VP (VP (VBZ is) (ADVP (RB directly)) (VP (VBN mediated) (PP (IN via) (NP (NP (DT the) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT2_))))))) (CC and) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT_))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT1_))))) (VP (VP (VBZ is) (ADVP (RB directly)) (VP (VBN mediated) (PP (IN via) (NP (NP (DT the) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT_))))))) (CC and) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN interaction)) (PP (IN between) (NP (NP (NN _PROT_)) (CC and) (NP (NN _PROT_))))) (VP (VP (VBZ is) (ADVP (RB directly)) (VP (VBN mediated) (PP (IN via) (NP (NP (DT the) (NN SH2) (NN domain)) (PP (IN of) (NP (NN _PROT1_))))))) (CC and) (VP (VBZ is) (ADJP (JJ dependent) (PP (IN on) (NP (NP (NN tyrosine) (NN phosphorylation)) (PP (IN of) (NP (NN _PROT2_))))))))) (. .)))
+1 #(S1 (S (PP (IN In) (NP (NN addition))) (, ,) (NP (PRP we)) (VP (VBP show) (SBAR (IN that) (S (NP (NP (DT the) (VBN conserved) (NN motif) (NN Y699) (NN MTP) (NN present)) (PP (IN in) (NP (NN _PROT1_)))) (VP (VBZ is) (NP (NP (DT the) (VBG binding) (NN site)) (PP (IN for) (NP (DT the) (NN _PROT2_) (NN SH2) (NN domain)))) (ADVP (FW in) (FW vitro)))))) (. .)))
-1 #(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP imply) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ is) (NP (NP (DT a) (JJ molecular) (NN adapter)) (SBAR (WHNP (WDT that)) (S (VP (VBZ regulates) (NP (NP (DT the) (NN function)) (PP (IN of) (NP (NN _PROT2_))) (PP (IN in) (NP (NP (NNS thymocytes)) (CC and) (NP (JJ peripheral) (NN T) (NNS cells)))))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN _PROT2_)) (-RRB- -RRB-))) (VP (VBZ is) (NP (NP (DT a) (NN hematopoietin)) (ADJP (JJ important) (PP (IN for) (NP (NP (NP (NN megakaryocyte) (NN proliferation)) (CC and) (NP (NN production))) (PP (IN of) (NP (NN blood) (NNS platelets))))))))) (. .)))
+1 #(S1 (S (S (NP (PRP We)) (VP (VBD sought) (S (VP (TO to) (VP (VB characterize) (SBAR (WHADVP (WRB how)) (S (NP (NN _PROT1_)) (VP (VP (VBZ binds)) (CC and) (VP (VBZ activates) (NP (NP (PRP$ its) (NN receptor)) (, ,) (NP (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ _PROT1_) (NN domain)) (PP (IN of) (NP (NP (NN _PROT2_)) (PRN (-LRB- -LRB-) (NP (NN TPO1-153)) (-RRB- -RRB-))))) (VP (VBZ has) (VP (VBN been) (VP (VBN fused) (PP (TO to) (NP (NP (DT the) (NN _PROT_) (NN coat) (NN protein)) (PP (IN of) (NP (NN M13) (NN bacteriophage))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ _PROT1_) (NN domain)) (PP (IN of) (NP (NP (NN _PROT_)) (PRN (-LRB- -LRB-) (NP (NN TPO1-153)) (-RRB- -RRB-))))) (VP (VBZ has) (VP (VBN been) (VP (VBN fused) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN coat) (NN protein)) (PP (IN of) (NP (NN M13) (NN bacteriophage))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ _PROT_) (NN domain)) (PP (IN of) (NP (NP (NN _PROT1_)) (PRN (-LRB- -LRB-) (NP (NN TPO1-153)) (-RRB- -RRB-))))) (VP (VBZ has) (VP (VBN been) (VP (VBN fused) (PP (TO to) (NP (NP (DT the) (NN _PROT2_) (NN coat) (NN protein)) (PP (IN of) (NP (NN M13) (NN bacteriophage))))))))) (. .)))
-1 #(S1 (S (S (NP (NN Phage) (JJ enzyme-linked) (JJ immunosorbent) (NN assay)) (VP (VBD was) (VP (VBN used) (S (VP (TO to) (VP (VB determine) (NP (NP (NNS affinities)) (PP (IN for) (NP (NP (NN binding)) (PP (TO to) (NP (CC both) (NP (DT the) (NN _PROT1_) (NN receptor)) (CC and) (NP (CD five) (NN _PROT2_) (JJ monoclonal) (NNS antibodies))))))))))))) (. .)))
-1 #(S1 (S (S (PP (IN In) (NP (NN contrast))) (, ,) (NP (NP (DT the) (JJ other) (CD three) (JJ monoclonal) (NNS antibodies)) (, ,) (SBAR (WHNP (WDT which)) (S (VP (VP (VBD were) (ADJP (JJ effective)) (PP (IN at) (S (VP (VBG blocking) (NP (NN _PROT1_) (NN activity)))))) (CC but) (VP (VBD did) (RB not) (VP (VB block) (NP (NP (JJ initial) (NN binding)) (PP (IN of) (NP (NN _PROT2_))) (PP (TO to) (NP (PRP$ its) (NN receptor))))))))) (, ,)) (VP (VBD had) (NP (NP (NNS epitopes)) (ADVP (RB predominantly))) (PP (IN on) (NP (NP (NN helix)) (CC or) (NP (CD 3)))))) (. .)))
-1 #(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP suggest) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ has) (NP (NP (CD two) (JJ distinct) (JJ receptor-binding) (NNS sites)) (SBAR (WHNP (WDT that)) (S (VP (VBP function) (S (VP (TO to) (VP (VB dimerize) (NP (NN _PROT2_) (NNS receptors)) (PP (IN in) (NP (DT a) (JJ sequential) (NN fashion))))))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (NN protein) (NN product)) (PP (IN of) (NP (NN _PROT1_) (NN proto-oncogene)))) (VP (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (JJ several) (NNS proteins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT2_)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN _PROT_) (NN _PROT_))))))))))) (, ,) (CC and) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB regulate) (NP (NN signalling)) (PP (IN by) (NP (JJ many) (NN cell) (NN surface) (NNS receptors)))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (NN protein) (NN product)) (PP (IN of) (NP (NN _PROT1_) (NN proto-oncogene)))) (VP (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (JJ several) (NNS proteins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_) (NN _PROT_))))))))))) (, ,) (CC and) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB regulate) (NP (NN signalling)) (PP (IN by) (NP (JJ many) (NN cell) (NN surface) (NNS receptors)))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (NN protein) (NN product)) (PP (IN of) (NP (NN _PROT1_) (NN proto-oncogene)))) (VP (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (JJ several) (NNS proteins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))))))))))) (, ,) (CC and) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB regulate) (NP (NN signalling)) (PP (IN by) (NP (JJ many) (NN cell) (NN surface) (NNS receptors)))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN protein) (NN product)) (PP (IN of) (NP (NN _PROT_) (NN proto-oncogene)))) (VP (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (JJ several) (NNS proteins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT2_)) (CC and) (NP (NN _PROT_) (NN _PROT_))))))))))) (, ,) (CC and) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB regulate) (NP (NN signalling)) (PP (IN by) (NP (JJ many) (NN cell) (NN surface) (NNS receptors)))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN protein) (NN product)) (PP (IN of) (NP (NN _PROT_) (NN proto-oncogene)))) (VP (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (JJ several) (NNS proteins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT1_)) (, ,) (NP (NN _PROT_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))))))))))) (, ,) (CC and) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB regulate) (NP (NN signalling)) (PP (IN by) (NP (JJ many) (NN cell) (NN surface) (NNS receptors)))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (NN protein) (NN product)) (PP (IN of) (NP (NN _PROT_) (NN proto-oncogene)))) (VP (VP (VBZ is) (VP (VBN known) (S (VP (TO to) (VP (VB interact) (PP (IN with) (NP (NP (JJ several) (NNS proteins)) (, ,) (PP (VBG including) (NP (NP (NN _PROT_)) (, ,) (NP (NN _PROT1_)) (CC and) (NP (NN _PROT2_) (NN _PROT2_))))))))))) (, ,) (CC and) (VP (VBZ is) (VP (VBN thought) (S (VP (TO to) (VP (VB regulate) (NP (NN signalling)) (PP (IN by) (NP (JJ many) (NN cell) (NN surface) (NNS receptors)))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ precise) (NN function)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN in) (NP (DT these) (NNS pathways)))) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (, ,) (SBAR (IN although) (S (NP (NP (DT a) (JJ genetic) (NN analysis)) (PP (IN in) (NP (NN Caenorhabditis) (NNS elegans)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN _PROT2_)) (VP (VBZ is) (NP (NP (DT a) (JJ negative) (NN regulator)) (PP (IN of) (NP (DT the) (JJ _PROT_) (NN _PROT_) (NN _PROT_) (NN _PROT_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ precise) (NN function)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN in) (NP (DT these) (NNS pathways)))) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (, ,) (SBAR (IN although) (S (NP (NP (DT a) (JJ genetic) (NN analysis)) (PP (IN in) (NP (NN Caenorhabditis) (NNS elegans)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (NP (NP (DT a) (JJ negative) (NN regulator)) (PP (IN of) (NP (DT the) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ precise) (NN function)) (PP (IN of) (NP (NN _PROT1_))) (PP (IN in) (NP (DT these) (NNS pathways)))) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (, ,) (SBAR (IN although) (S (NP (NP (DT a) (JJ genetic) (NN analysis)) (PP (IN in) (NP (NN Caenorhabditis) (NNS elegans)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (NP (NP (DT a) (JJ negative) (NN regulator)) (PP (IN of) (NP (DT the) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ precise) (NN function)) (PP (IN of) (NP (NN _PROT_))) (PP (IN in) (NP (DT these) (NNS pathways)))) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (, ,) (SBAR (IN although) (S (NP (NP (DT a) (JJ genetic) (NN analysis)) (PP (IN in) (NP (NN Caenorhabditis) (NNS elegans)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ is) (NP (NP (DT a) (JJ negative) (NN regulator)) (PP (IN of) (NP (DT the) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT_)))))))))))) (. .)))
+1 #(S1 (S (S (NP (NP (DT The) (JJ precise) (NN function)) (PP (IN of) (NP (NN _PROT_))) (PP (IN in) (NP (DT these) (NNS pathways)))) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (, ,) (SBAR (IN although) (S (NP (NP (DT a) (JJ genetic) (NN analysis)) (PP (IN in) (NP (NN Caenorhabditis) (NNS elegans)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN _PROT1_)) (VP (VBZ is) (NP (NP (DT a) (JJ negative) (NN regulator)) (PP (IN of) (NP (DT the) (JJ _PROT2_) (NN _PROT2_) (NN _PROT2_) (NN _PROT2_)))))))))))) (. .)))
-1 #(S1 (S (S (NP (NP (DT The) (JJ precise) (NN function)) (PP (IN of) (NP (NN _PROT_))) (PP (IN in) (NP (DT these) (NNS pathways)))) (VP (VBZ is) (RB not) (ADJP (JJ clear)) (, ,) (SBAR (IN although) (S (NP (NP (DT a) (JJ genetic) (NN analysis)) (PP (IN in) (NP (NN Caenorhabditis) (NNS elegans)))) (VP (VBZ suggests) (SBAR (IN that) (S (NP (NN _PROT_)) (VP (VBZ is) (NP (NP (DT a) (JJ negative) (NN regulator)) (PP (IN of) (NP (DT the) (JJ _PROT1_AND_PROT2_) (NN _PROT1_AND_PROT2_) (NN _PROT1_AND_PROT2_) (NN _PROT2_)))))))))))) (. .)))
+1 #(S1 (S (S (NP (DT The) (NN screen)) (VP (VBD identified) (NP (NP (NNS interactions)) (VP (VBG involving) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (CD two) (NN 14-3-3) (NNS isoforms)) (, ,) (NP (NP (NN _PROT2_) (CD _PROT2_)) (, ,) (NP (NP (JJ human) (JJ unconventional) (NN myosin)) (NN IC)) (, ,) (CC and) (NP (NP (DT a) (ADJP (RB recently) (VBN identified)) (NN SH3) (NN domain) (NN containing) (NN protein)) (, ,) (NP (NN _PROT_) (NN _PROT_)))))))))) (. .)))
+1 #(S1 (S (S (NP (DT The) (NN screen)) (VP (VBD identified) (NP (NP (NNS interactions)) (VP (VBG involving) (NP (NP (NN _PROT1_)) (CC and) (NP (NP (CD two) (NN 14-3-3) (NNS isoforms)) (, ,) (NP (NP (NN _PROT_) (CD _PROT_)) (, ,) (NP (NP (JJ human) (JJ unconventional) (NN myosin)) (NN IC)) (, ,) (CC and) (NP (NP (DT a) (ADJP (RB recently) (VBN identified)) (NN SH3) (NN domain) (NN containing) (NN protein)) (, ,) (NP (NN _PROT2_) (NN _PROT2_)))))))))) (. .)))
-1 #(S1 (S (S (NP (DT The) (NN screen)) (VP (VBD identified) (NP (NP (NNS interactions)) (VP (VBG involving) (NP (NP (NN _PROT_)) (CC and) (NP (NP (CD two) (NN 14-3-3) (NNS isoforms)) (, ,) (NP (NP (NN _PROT1_) (CD _PROT1_)) (, ,) (NP (NP (JJ human) (JJ unconventional) (NN myosin)) (NN IC)) (, ,) (CC and) (NP (NP (DT a) (ADJP (RB recently) (VBN identified)) (NN SH3) (NN domain) (NN containing) (NN protein)) (, ,) (NP (NN _PROT2_) (NN _PROT2_)))))))))) (. .)))
